Comparing	O
regions	O
of	O
the	O
Epstein-Barr	B-protein
virus	I-protein
ZEBRA	I-protein
protein	I-protein
which	O
function	O
as	O
transcriptional	B-DNA
activating	I-DNA
sequences	I-DNA
in	O
Saccharomyces	O
cerevisiae	O
and	O
in	O
B	B-cell_type
cells	I-cell_type
.	O

The	O
ZEBRA	B-protein
protein	I-protein
activates	O
expression	O
of	O
Epstein-Barr	O
virus	O
early-lytic-cycle	B-DNA
genes	I-DNA
in	O
human	B-cell_type
B	I-cell_type
lymphocytes	I-cell_type
.	O

Here	O
it	O
is	O
shown	O
that	O
ZEBRA	B-protein
also	O
behaves	O
as	O
a	O
sequence-specific	B-protein
transcriptional	I-protein
activator	I-protein
in	O
Saccharomyces	O
cerevisiae	O
.	O

Deletional	O
mutagenesis	O
defined	O
three	O
regions	O
of	O
ZEBRA	B-protein
that	O
participate	O
in	O
activation	O
in	O
S.	O
cerevisiae	O
.	O

These	O
regions	O
are	O
designated	O
YI	B-protein
(	O
amino	B-protein
acids	I-protein
[	I-protein
aa	I-protein
]	I-protein
1	I-protein
to	I-protein
25	I-protein
)	O
,	O
YII	B-protein
(	O
aa	B-protein
51	I-protein
to	I-protein
102	I-protein
)	O
,	O
and	O
YIII	B-protein
(	O
aa	B-protein
228	I-protein
to	I-protein
245	I-protein
)	O
.	O

Two	O
of	O
the	O
three	O
regions	O
of	O
the	O
native	O
ZEBRA	B-protein
protein	I-protein
act	O
together	O
to	O
mediate	O
activation	O
when	O
assayed	O
on	O
ZEBRA	B-protein
binding	I-protein
sites	I-protein
.	O

However	O
,	O
when	O
fused	O
to	O
the	O
DNA	B-protein
binding	I-protein
domain	I-protein
of	O
GAL	B-protein
4	O
and	O
assayed	O
on	O
GAL4	B-protein
binding	I-protein
sites	I-protein
,	O
regions	B-protein
YII	I-protein
and	I-protein
YIII	I-protein
were	O
each	O
sufficient	O
to	O
confer	O
activation	O
in	O
S.	O
cerevisiae	O
.	O

Regions	O
of	O
ZEBRA	B-protein
which	O
affected	O
activation	O
in	O
S.	O
cerevisiae	O
were	O
also	O
required	O
in	O
human	B-cell_type
B	I-cell_type
lymphocytes	I-cell_type
.	O

The	O
amino-terminal	B-protein
region	I-protein
of	O
ZEBRA	B-protein
(	O
aa	B-protein
1	I-protein
to	I-protein
98	I-protein
)	O
was	O
required	O
for	O
activation	O
both	O
in	O
S.	O
cerevisiae	O
and	O
in	O
human	B-cell_type
B	I-cell_type
cells	I-cell_type
;	O
deletion	O
of	O
the	O
carboxy-terminal	B-protein
18	I-protein
aa	I-protein
also	O
significantly	O
reduced	O
activation	O
in	O
both	O
cell	O
types	O
.	O

Thus	O
,	O
the	O
behavior	O
of	O
ZEBRA	B-protein
in	O
human	B-cell_type
B	I-cell_type
cells	I-cell_type
and	O
S.	O
cerevisiae	O
suggests	O
that	O
the	O
protein	O
contains	O
universal	B-protein
activation	I-protein
motifs	I-protein
that	O
interact	O
with	O
conserved	O
components	O
of	O
the	O
transcription	O
machinery	O
.	O

However	O
,	O
certain	O
deletion	B-protein
mutants	I-protein
of	O
ZEBRA	B-protein
containing	O
mutations	O
in	O
the	O
N-terminal	B-protein
region	I-protein
exhibited	O
discordant	O
behaviors	O
in	O
S.	O
cerevisiae	O
and	O
in	O
B	O
cells	O
.	O

For	O
example	O
,	O
deletion	O
of	O
ZEBRA	B-protein
aa	I-protein
26	I-protein
to	I-protein
51	I-protein
impaired	O
activation	O
to	O
a	O
great	O
extent	O
in	O
B	B-cell_type
cells	I-cell_type
but	O
had	O
little	O
or	O
no	O
effect	O
in	O
S.	O
cerevisiae	O
.	O

The	O
discordant	O
mutants	O
may	O
reflect	O
interactions	O
with	O
a	O
variable	B-protein
domain	I-protein
of	O
a	O
conserved	O
component	O
or	O
unique	O
interactions	O
with	O
specialized	O
components	O
of	O
the	O
basal	O
transcription	O
apparatus	O
in	O
different	O
cells	O
.	O

Journat	NULL
or	NULL
ViroLogy	NULL
,	NULL
Dec.	NULL
1993	NULL
,	NULL
p.	NULL
7472-7481	NULL
0022-538	NULL
X/93/127472-10	NULL
$	NULL
02.00/0	NULL
Copyright	NULL
©	NULL
1993	NULL
,	NULL
American	NULL
Society	NULL
for	NULL
Microbiology	NULL
Vol	NULL
.	NULL

67	NULL
,	NULL
No	NULL
.	NULL

12	NULL
Comparing	NULL
Regions	NULL
of	NULL
the	NULL
Epstein-Barr	NULL
Virus	NULL
ZEBRA	NULL
Protein	NULL
Which	NULL
Function	NULL
as	NULL
Transcriptional	NULL
Activating	NULL
Sequences	NULL
in	NULL
Saccharomyces	NULL
cerevisiae	NULL
and	NULL
in	NULL
B	NULL
Cells	NULL
GEORGE	NULL
MILLER	NULL
,	NULL
'*	NULL
HOWARD	NULL
HIMMELFARB	NULL
,	NULL
LEE	NULL
HESTON	NULL
,	NULL
'	NULL
JILL	NULL
COUNTRYMAN	NULL
,	NULL
!	NULL

LYNDLE	NULL
GRADOVILLE	NULL
,	NULL
'	NULL
RAYMOND	NULL
BAUMANN	NULL
,	NULL
!	NULL

TIANHUAI	NULL
CHI	NULL
,	NULL
*	NULL
anp	NULL
MICHAEL	NULL
CAREY	NULL
Departments	NULL
of	NULL
Pediatrics	NULL
,	NULL
Epidemiology	NULL
and	NULL
Public	NULL
Health	NULL
,	NULL
and	NULL
Molecular	NULL
Biophysics	NULL
and	NULL
Biochemistry	NULL
,	NULL
Yale	NULL
University	NULL
School	NULL
of	NULL
Medicine	NULL
,	NULL
New	NULL
Haven	NULL
,	NULL
Connecticut	NULL
06510-8064	NULL
;	NULL
Department	NULL
of	NULL
Biochemistry	NULL
and	NULL
Molecular	NULL
Biology	NULL
,	NULL
Harvard	NULL
University	NULL
,	NULL
Cambridge	NULL
,	NULL
Massachusetts	NULL
02115	NULL
``	NULL
;	NULL
and	NULL
Department	NULL
of	NULL
Biological	NULL
Chemistry	NULL
,	NULL
University	NULL
of	NULL
California	NULL
,	NULL
Los	NULL
Angeles	NULL
,	NULL
School	NULL
of	NULL
Medicine	NULL
,	NULL
Los	NULL
Angeles	NULL
,	NULL
California	NULL
90024°	NULL
Received	NULL
15	NULL
July	NULL
1993/Accepted	NULL
13	NULL
September	NULL
1993	NULL
The	NULL
ZEBRA	NULL
protein	NULL
activates	NULL
expression	NULL
of	NULL
Epstein-Barr	NULL
virus	NULL
early-lytic-cycle	NULL
genes	NULL
in	NULL
human	NULL
B	NULL
lymphocytes	NULL
.	NULL

Here	NULL
it	NULL
is	NULL
shown	NULL
that	NULL
ZEBRA	NULL
also	NULL
behaves	NULL
as	NULL
a	NULL
sequence-specific	NULL
transcriptional	NULL
activator	NULL
in	NULL
Saccharomyces	NULL
cerevisiae	NULL
.	NULL

Deletional	NULL
mutagenesis	NULL
defined	NULL
three	NULL
regions	NULL
of	NULL
ZEBRA	NULL
that	NULL
participate	NULL
in	NULL
activation	NULL
in	NULL
S.	NULL
cerevisiae	NULL
.	NULL

These	NULL
regions	NULL
are	NULL
designated	NULL
YI	NULL
(	NULL
amino	NULL
acids	NULL
[	NULL
aa	NULL
]	NULL
1	NULL
to	NULL
25	NULL
)	NULL
,	NULL
YI	NULL
(	NULL
aa	NULL
51	NULL
to	NULL
102	NULL
)	NULL
,	NULL
and	NULL
YIII	NULL
(	NULL
aa	NULL
228	NULL
to	NULL
245	NULL
)	NULL
.	NULL

Two	NULL
of	NULL
the	NULL
three	NULL
regions	NULL
of	NULL
the	NULL
native	NULL
ZEBRA	NULL
protein	NULL
act	NULL
together	NULL
to	NULL
mediate	NULL
activation	NULL
when	NULL
assayed	NULL
on	NULL
ZEBRA	NULL
binding	NULL
sites	NULL
.	NULL

However	NULL
,	NULL
when	NULL
fused	NULL
to	NULL
the	NULL
DNA	NULL
binding	NULL
domain	NULL
of	NULL
GAL4	NULL
and	NULL
assayed	NULL
on	NULL
GALA	NULL
binding	NULL
sites	NULL
,	NULL
regions	NULL
YH	NULL
and	NULL
YIII	NULL
were	NULL
each	NULL
sufficient	NULL
to	NULL
confer	NULL
activation	NULL
in	NULL
S.	NULL
cerevisiae	NULL
.	NULL

Regions	NULL
of	NULL
ZEBRA	NULL
which	NULL
affected	NULL
activation	NULL
in	NULL
S.	NULL
cerevisiae	NULL
were	NULL
also	NULL
required	NULL
in	NULL
human	NULL
B	NULL
lymphocytes	NULL
.	NULL

The	NULL
amino-terminal	NULL
region	NULL
of	NULL
ZEBRA	NULL
(	NULL
aa	NULL
1	NULL
to	NULL
98	NULL
)	NULL
was	NULL
required	NULL
for	NULL
activation	NULL
both	NULL
in	NULL
S.	NULL
cerevisiae	NULL
and	NULL
in	NULL
human	NULL
B	NULL
cells	NULL
;	NULL
deletion	NULL
of	NULL
the	NULL
carboxy-terminal	NULL
18	NULL
aa	NULL
also	NULL
significantly	NULL
reduced	NULL
activation	NULL
in	NULL
both	NULL
cell	NULL
types	NULL
.	NULL

Thus	NULL
,	NULL
the	NULL
behavior	NULL
of	NULL
ZEBRA	NULL
in	NULL
human	NULL
B	NULL
cells	NULL
and	NULL
8.	NULL
cerevisiae	NULL
suggests	NULL
that	NULL
the	NULL
protein	NULL
contains	NULL
universal	NULL
activation	NULL
motifs	NULL
that	NULL
interact	NULL
with	NULL
conserved	NULL
components	NULL
of	NULL
the	NULL
transcription	NULL
machinery	NULL
.	NULL

However	NULL
,	NULL
certain	NULL
deletion	NULL
mutants	NULL
of	NULL
ZEBRA	NULL
containing	NULL
mutations	NULL
in	NULL
the	NULL
N-terminal	NULL
region	NULL
exhibited	NULL
discordant	NULL
behaviors	NULL
in	NULL
S.	NULL
cerevisiae	NULL
and	NULL
in	NULL
B	NULL
cells	NULL
.	NULL

For	NULL
example	NULL
,	NULL
deletion	NULL
of	NULL
ZEBRA	NULL
aa	NULL
26	NULL
to	NULL
51	NULL
impaired	NULL
activation	NULL
to	NULL
a	NULL
great	NULL
extent	NULL
in	NULL
B	NULL
cells	NULL
but	NULL
had	NULL
little	NULL
or	NULL
no	NULL
effect	NULL
in	NULL
S.	NULL
cerevisiae	NULL
.	NULL

The	NULL
discordant	NULL
mutants	NULL
may	NULL
reflect	NULL
interactions	NULL
with	NULL
a	NULL
variable	NULL
domain	NULL
of	NULL
a	NULL
conserved	NULL
component	NULL
or	NULL
unique	NULL
interactions	NULL
with	NULL
specialized	NULL
components	NULL
of	NULL
the	NULL
basal	NULL
transcription	NULL
apparatus	NULL
in	NULL
different	NULL
cells	NULL
.	NULL

ZEBRA	NULL
protein	NULL
initiates	NULL
a	NULL
cascade	NULL
of	NULL
events	NULL
leading	NULL
to	NULL
expression	NULL
of	NULL
Epstein-Barr	NULL
virus	NULL
(	NULL
EBV	NULL
)	NULL
lytic-cycle	NULL
genes	NULL
(	NULL
1	NULL
,	NULL
7	NULL
,	NULL
32	NULL
)	NULL
.	NULL

ZEBRA	NULL
activates	NULL
transcription	NULL
by	NULL
binding	NULL
to	NULL
ZEBRA	NULL
response	NULL
elements	NULL
(	NULL
ZREs	NULL
)	NULL
found	NULL
in	NULL
the	NULL
promoters	NULL
of	NULL
its	NULL
target	NULL
EBV	NULL
lytic-cycle	NULL
genes	NULL
(	NULL
5	NULL
,	NULL
9	NULL
,	NULL
28	NULL
,	NULL
47	NULL
,	NULL
49	NULL
)	NULL
.	NULL

Some	NULL
ZREs	NULL
are	NULL
related	NULL
to	NULL
mammalian	NULL
AP-1	NULL
recognition	NULL
sequences	NULL
;	NULL
however	NULL
,	NULL
ZEBRA	NULL
also	NULL
recognizes	NULL
sites	NULL
which	NULL
are	NULL
distinct	NULL
from	NULL
those	NULL
bound	NULL
by	NULL
AP-1	NULL
.	NULL

Like	NULL
other	NULL
eukaryotic	NULL
activators	NULL
,	NULL
ZEBRA	NULL
is	NULL
a	NULL
modular	NULL
protein	NULL
(	NULL
37	NULL
)	NULL
,	NULL
and	NULL
its	NULL
domain	NULL
structure	NULL
generally	NULL
corresponds	NULL
to	NULL
its	NULL
exon	NULL
composition	NULL
.	NULL

An	NULL
activating	NULL
region	NULL
is	NULL
present	NULL
in	NULL
the	NULL
N-terminal	NULL
portion	NULL
(	NULL
approximately	NULL
amino	NULL
acids	NULL
[	NULL
aa	NULL
]	NULL
1	NULL
to	NULL
100	NULL
)	NULL
,	NULL
and	NULL
the	NULL
DNA	NULL
recognition	NULL
and	NULL
dimerization	NULL
domains	NULL
are	NULL
found	NULL
in	NULL
the	NULL
C-terminal	NULL
portion	NULL
(	NULL
aa	NULL
167	NULL
to	NULL
245	NULL
)	NULL
(	NULL
10	NULL
,	NULL
11	NULL
,	NULL
15	NULL
,	NULL
26	NULL
,	NULL
36	NULL
,	NULL
47	NULL
)	NULL
.	NULL

ZEBRA	NULL
stimulates	NULL
transcription	NULL
in	NULL
many	NULL
different	NULL
mammalian	NULL
cell	NULL
types	NULL
and	NULL
in	NULL
vitro	NULL
in	NULL
HeLa	NULL
cell	NULL
extracts	NULL
(	NULL
4	NULL
,	NULL
26	NULL
)	NULL
.	NULL

Thus	NULL
,	NULL
activation	NULL
of	NULL
transcription	NULL
by	NULL
ZEBRA	NULL
requires	NULL
neither	NULL
B-cell-specific	NULL
nor	NULL
EBV-specific	NULL
factors	NULL
.	NULL

These	NULL
results	NULL
suggest	NULL
that	NULL
ZEBRA	NULL
interacts	NULL
with	NULL
one	NULL
or	NULL
more	NULL
conserved	NULL
components	NULL
of	NULL
the	NULL
mammalian	NULL
basal	NULL
transcription	NULL
apparatus	NULL
.	NULL

Some	NULL
mammalian	NULL
cellular	NULL
and	NULL
viral	NULL
transcriptional	NULL
activators	NULL
function	NULL
in	NULL
Saccharomyces	NULL
cerevisiae	NULL
cells	NULL
,	NULL
and	NULL
certain	NULL
yeast	NULL
activators	NULL
function	NULL
in	NULL
mammalian	NULL
cells	NULL
(	NULL
10	NULL
,	NULL
12	NULL
,	NULL
23	NULL
,	NULL
24	NULL
,	NULL
25	NULL
,	NULL
31	NULL
,	NULL
33	NULL
,	NULL
34	NULL
,	NULL
42	NULL
,	NULL
45	NULL
,	NULL
50	NULL
)	NULL
.	NULL

In	NULL
one	NULL
approach	NULL
to	NULL
demonstrate	NULL
that	NULL
a	NULL
mammalian	NULL
activating	NULL
region	NULL
functions	NULL
in	NULL
S.	NULL
cerevisiae	NULL
,	NULL
the	NULL
activator	NULL
,	NULL
or	NULL
a	NULL
portion	NULL
thereof	NULL
,	NULL
is	NULL
fused	NULL
to	NULL
a	NULL
heterologous	NULL
DNA	NULL
binding	NULL
domain	NULL
.	NULL

For	NULL
example	NULL
,	NULL
c-fos	NULL
fused	NULL
to	NULL
the	NULL
DNA	NULL
binding	NULL
*	NULL
Corresponding	NULL
author	NULL
.	NULL

7472	NULL
domain	NULL
present	NULL
in	NULL
aa	NULL
1	NULL
to	NULL
87	NULL
of	NULL
the	NULL
bacterial	NULL
LexA	NULL
repressor	NULL
protein	NULL
will	NULL
stimulate	NULL
transcription	NULL
in	NULL
S.	NULL
cerevisiae	NULL
of	NULL
reporter	NULL
genes	NULL
bearing	NULL
nearby	NULL
LexA-binding	NULL
sites	NULL
(	NULL
25	NULL
)	NULL
.	NULL

Similarly	NULL
,	NULL
the	NULL
activating	NULL
domain	NULL
of	NULL
the	NULL
mammalian	NULL
herpes	NULL
simplex	NULL
virus	NULL
protein	NULL
VP16	NULL
,	NULL
when	NULL
fused	NULL
to	NULL
the	NULL
DNA	NULL
binding	NULL
domain	NULL
contained	NULL
in	NULL
aa	NULL
1	NULL
to	NULL
147	NULL
of	NULL
the	NULL
yeast	NULL
GAL4	NULL
protein	NULL
,	NULL
will	NULL
activate	NULL
transcription	NULL
from	NULL
GAL4	NULL
sites	NULL
in	NULL
S.	NULL
cerevisiae	NULL
(	NULL
2	NULL
,	NULL
6	NULL
)	NULL
.	NULL

When	NULL
the	NULL
mammalian	NULL
activator	NULL
is	NULL
itself	NULL
a	NULL
DNA	NULL
binding	NULL
protein	NULL
,	NULL
such	NULL
as	NULL
the	NULL
bovine	NULL
papillomavirus	NULL
E2	NULL
protein	NULL
,	NULL
it	NULL
can	NULL
be	NULL
shown	NULL
to	NULL
stimulate	NULL
transcription	NULL
in	NULL
S.	NULL
cerevisige	NULL
from	NULL
reporter	NULL
genes	NULL
which	NULL
bear	NULL
E2	NULL
cognate	NULL
binding	NULL
sites	NULL
(	NULL
24	NULL
,	NULL
34	NULL
)	NULL
.	NULL

The	NULL
activity	NULL
of	NULL
the	NULL
bovine	NULL
papillomavirus	NULL
E2	NULL
protein	NULL
can	NULL
be	NULL
measured	NULL
in	NULL
such	NULL
an	NULL
assay	NULL
because	NULL
E2	NULL
binding	NULL
sites	NULL
are	NULL
not	NULL
recognized	NULL
by	NULL
a	NULL
yeast	NULL
factor	NULL
.	NULL

Among	NULL
the	NULL
long-range	NULL
objectives	NULL
of	NULL
such	NULL
experiments	NULL
in	NULL
$	NULL
.	NULL

cerevisiae	NULL
is	NULL
to	NULL
define	NULL
conserved	NULL
cellular	NULL
proteins	NULL
which	NULL
interact	NULL
with	NULL
the	NULL
mammalian	NULL
activator	NULL
and	NULL
to	NULL
analyze	NULL
the	NULL
mode	NULL
of	NULL
activation	NULL
of	NULL
downstream	NULL
target	NULL
genes	NULL
.	NULL

Experiments	NULL
in	NULL
S.	NULL
cerevisiae	NULL
may	NULL
help	NULL
to	NULL
distinguish	NULL
transcriptional	NULL
regulatory	NULL
regions	NULL
which	NULL
are	NULL
directly	NULL
and	NULL
solely	NULL
acted	NULL
upon	NULL
by	NULL
the	NULL
activator	NULL
from	NULL
those	NULL
that	NULL
require	NULL
complex	NULL
interactions	NULL
between	NULL
groups	NULL
of	NULL
proteins	NULL
bound	NULL
to	NULL
the	NULL
same	NULL
promoter	NULL
.	NULL

The	NULL
experiments	NULL
presented	NULL
here	NULL
have	NULL
explored	NULL
the	NULL
capacity	NULL
of	NULL
ZEBRA	NULL
to	NULL
behave	NULL
as	NULL
an	NULL
activator	NULL
in	NULL
S.	NULL
cerevisiae	NULL
.	NULL

These	NULL
experiments	NULL
show	NULL
that	NULL
ZEBRA	NULL
is	NULL
able	NULL
to	NULL
activate	NULL
transcription	NULL
in	NULL
S.	NULL
cerevisiae	NULL
when	NULL
bound	NULL
to	NULL
promoters	NULL
by	NULL
its	NULL
own	NULL
DNA	NULL
binding	NULL
domain	NULL
.	NULL

Portions	NULL
of	NULL
ZEBRA	NULL
also	NULL
function	NULL
as	NULL
activating	NULL
regions	NULL
in	NULL
S.	NULL
cerevisiae	NULL
when	NULL
fused	NULL
to	NULL
the	NULL
DNA	NULL
binding	NULL
domain	NULL
of	NULL
GALA	NULL
.	NULL

By	NULL
use	NULL
of	NULL
deletion	NULL
mutants	NULL
,	NULL
the	NULL
regions	NULL
of	NULL
ZEBRA	NULL
necessary	NULL
Vor	NULL
.	NULL

67	NULL
.	NULL

1993	NULL
for	NULL
activation	NULL
of	NULL
transcription	NULL
in	NULL
$	NULL
8	NULL
.	NULL

cerevisiae	NULL
and	NULL
in	NULL
human	NULL
B	NULL
lymphocytes	NULL
were	NULL
compared	NULL
.	NULL

One	NULL
region	NULL
of	NULL
ZEBRA	NULL
which	NULL
is	NULL
dispensable	NULL
for	NULL
activation	NULL
of	NULL
transcription	NULL
in	NULL
S.	NULL
cerevisiae	NULL
is	NULL
required	NULL
in	NULL
human	NULL
B	NULL
cells	NULL
.	NULL

MATERIALS	NULL
AND	NULL
METHODS	NULL
Yeast	NULL
strains	NULL
and	NULL
media	NULL
.	NULL

Activation	NULL
by	NULL
intact	NULL
ZEBRA	NULL
and	NULL
by	NULL
mutants	NULL
with	NULL
internal	NULL
,	NULL
N-terminal	NULL
,	NULL
C-terminal	NULL
,	NULL
and	NULL
point	NULL
mutations	NULL
thereof	NULL
was	NULL
assayed	NULL
in	NULL
yeast	NULL
strain	NULL
W3031A	NULL
(	NULL
MATa	NULL
can	NULL
l-100	NULL
his3-11,15	NULL
leu2-3,112	NULL
trpl-1	NULL
ura3-1	NULL
ade2-1	NULL
)	NULL
obtained	NULL
from	NULL
Rodney	NULL
Rothstein	NULL
,	NULL
Columbia	NULL
University	NULL
College	NULL
of	NULL
Physicians	NULL
and	NULL
Surgeons	NULL
.	NULL

This	NULL
strain	NULL
is	NULL
GAL4*	NULL
;	NULL
GALA	NULL
is	NULL
required	NULL
to	NULL
activate	NULL
the	NULL
GALLI	NULL
promoter	NULL
from	NULL
which	NULL
ZEBRA	NULL
was	NULL
expressed	NULL
(	NULL
22	NULL
)	NULL
.	NULL

Activation	NULL
by	NULL
chimeric	NULL
proteins	NULL
containing	NULL
the	NULL
DNA	NULL
binding	NULL
domain	NULL
of	NULL
GAL4	NULL
fused	NULL
to	NULL
ZEBRA	NULL
or	NULL
portions	NULL
of	NULL
ZEBRA	NULL
was	NULL
assayed	NULL
in	NULL
several	NULL
yeast	NULL
strains	NULL
.	NULL

Strain	NULL
YT6	NULL
:	NULL
:171	NULL
(	NULL
MATa	NULL
gal4-542	NULL
gal80-538	NULL
ura	NULL
3-52	NULL
his	NULL
3-200	NULL
ade2-101	NULL
adel	NULL
lys2-801	NULL
trp1-901	NULL
arol	NULL
leu2-3,112	NULL
mell	NULL
Met	NULL
)	NULL
bears	NULL
an	NULL
integrated	NULL
reporter	NULL
which	NULL
contains	NULL
a	NULL
portion	NULL
of	NULL
the	NULL
GAL	NULL
]	NULL
promoter	NULL
,	NULL
UAS	NULL
,	NULL
;	NULL
fused	NULL
to	NULL
lacZ	NULL
(	NULL
51	NULL
)	NULL
.	NULL

Strain	NULL
P56:171	NULL
is	NULL
con-genic	NULL
to	NULL
YT6	NULL
:	NULL
:171	NULL
but	NULL
bears	NULL
the	NULL
GAL1IP	NULL
(	NULL
potentiator	NULL
)	NULL
mutation	NULL
,	NULL
which	NULL
converts	NULL
weak	NULL
activators	NULL
,	NULL
fused	NULL
to	NULL
the	NULL
DNA	NULL
binding	NULL
domain	NULL
of	NULL
GAL4	NULL
,	NULL
into	NULL
strong	NULL
activators	NULL
(	NULL
18	NULL
)	NULL
.	NULL

Strain	NULL
JPY9	NULL
(	NULL
MATa	NULL
ura3-52	NULL
his3	NULL
A200	NULL
AI	NULL
trpl	NULL
A63	NULL
lys2	NULL
A385	NULL
gal4A11	NULL
)	NULL
was	NULL
derived	NULL
from	NULL
FY250	NULL
provided	NULL
by	NULL
Fred	NULL
Winston	NULL
,	NULL
Department	NULL
of	NULL
Genetics	NULL
,	NULL
Harvard	NULL
Medical	NULL
School	NULL
.	NULL

Media	NULL
were	NULL
prepared	NULL
as	NULL
described	NULL
by	NULL
Sherman	NULL
et	NULL
al	NULL
.	NULL

(	NULL
43	NULL
)	NULL
.	NULL

Reporters	NULL
.	NULL

The	NULL
reporter	NULL
plasmid	NULL
pCZA	NULL
,	NULL
shown	NULL
in	NULL
Fig	NULL
.	NULL

1A	NULL
,	NULL
contains	NULL
a	NULL
minimal	NULL
CYCZ/	NULL
promoter	NULL
,	NULL
including	NULL
the	NULL
TATA	NULL
element	NULL
,	NULL
fused	NULL
to	NULL
the	NULL
B-galactosidase	NULL
gene	NULL
(	NULL
28	NULL
)	NULL
.	NULL

It	NULL
also	NULL
contains	NULL
the	NULL
selectable	NULL
gene	NULL
URA3	NULL
and	NULL
a	NULL
yeast	NULL
chromosomal	NULL
origin	NULL
of	NULL
replication	NULL
and	NULL
a	NULL
centromere	NULL
(	NULL
CEN4	NULL
)	NULL
.	NULL

Oli-gomers	NULL
containing	NULL
different	NULL
numbers	NULL
(	NULL
1	NULL
,	NULL
3	NULL
,	NULL
5	NULL
,	NULL
or	NULL
7	NULL
)	NULL
of	NULL
ZIIIB	NULL
sites	NULL
were	NULL
inserted	NULL
into	NULL
an	NULL
Xbatl	NULL
site	NULL
in	NULL
a	NULL
polylinker	NULL
upstream	NULL
of	NULL
the	NULL
CYC	NULL
!	NULL

-lacZ	NULL
fusion	NULL
carried	NULL
on	NULL
this	NULL
plasmid	NULL
(	NULL
4	NULL
)	NULL
.	NULL

The	NULL
sequence	NULL
of	NULL
the	NULL
14-bp	NULL
oligonucleotide	NULL
used	NULL
to	NULL
make	NULL
these	NULL
reporters	NULL
is	NULL
5°	NULL
GGCATTGCTAATGT	NULL
3	NULL
'	NULL
.	NULL

(	NULL
The	NULL
ZIIIB	NULL
site	NULL
is	NULL
underlined	NULL
.	NULL
)	NULL

A	NULL
reporter	NULL
which	NULL
lacks	NULL
ZEBRA	NULL
binding	NULL
sites	NULL
contained	NULL
a	NULL
714-bp	NULL
EcoRI-to-Ncol	NULL
fragment	NULL
of	NULL
EBV	NULL
DNA	NULL
which	NULL
encompasses	NULL
the	NULL
repeated	NULL
element	NULL
in	NULL
orfP	NULL
inserted	NULL
into	NULL
the	NULL
EcoRI	NULL
site	NULL
of	NULL
the	NULL
polylinker	NULL
.	NULL

The	NULL
reporter	NULL
3GAL/CZ	NULL
contains	NULL
three	NULL
oligomerized	NULL
17-mer	NULL
GAL4	NULL
binding	NULL
sites	NULL
in	NULL
the	NULL
pCZA	NULL
polylinker	NULL
(	NULL
6	NULL
)	NULL
.	NULL

Activators	NULL
.	NULL

The	NULL
plasmid	NULL
vector	NULL
for	NULL
the	NULL
activators	NULL
was	NULL
pBM125	NULL
carrying	NULL
a	NULL
LEU2	NULL
marker	NULL
,	NULL
a	NULL
gift	NULL
from	NULL
James	NULL
Wang	NULL
,	NULL
Harvard	NULL
University	NULL
(	NULL
Fig	NULL
.	NULL

1B	NULL
)	NULL
.	NULL

In	NULL
pBM125	NULL
,	NULL
an	NULL
850-bp	NULL
EcoRI-to-BamHI	NULL
fragment	NULL
contains	NULL
the	NULL
galactose-inducible	NULL
GAL	NULL
/-GALIO	NULL
promoter	NULL
(	NULL
22	NULL
)	NULL
.	NULL

pBM125	NULL
contains	NULL
an	NULL
ARSZ	NULL
origin	NULL
of	NULL
replication	NULL
and	NULL
CEN4	NULL
.	NULL

The	NULL
activator	NULL
pBM125/Z	NULL
(	NULL
1-245	NULL
)	NULL
[	NULL
Z	NULL
(	NULL
1-245	NULL
)	NULL
]	NULL
contains	NULL
a	NULL
BZLFI	NULL
cDNA	NULL
inserted	NULL
into	NULL
the	NULL
unique	NULL
BamHI	NULL
site	NULL
of	NULL
pBM125	NULL
.	NULL

In	NULL
the	NULL
activator	NULL
Z	NULL
(	NULL
1-227	NULL
)	NULL
+VP16	NULL
,	NULL
aa	NULL
1	NULL
to	NULL
227	NULL
of	NULL
the	NULL
ZEBRA	NULL
cDNA	NULL
have	NULL
been	NULL
fused	NULL
in	NULL
frame	NULL
at	NULL
the	NULL
HinclI	NULL
site	NULL
with	NULL
aa	NULL
411	NULL
to	NULL
490	NULL
of	NULL
VP16	NULL
(	NULL
1	NULL
,	NULL
48	NULL
)	NULL
;	NULL
this	NULL
was	NULL
cloned	NULL
as	NULL
a	NULL
BamHI	NULL
fragment	NULL
into	NULL
pBM125	NULL
.	NULL

Several	NULL
internal-deletion	NULL
mutants	NULL
of	NULL
ZEBRA	NULL
were	NULL
cloned	NULL
into	NULL
pBM125	NULL
as	NULL
BamHI	NULL
or	NULL
BamHI-to-Sall	NULL
fragments	NULL
.	NULL

These	NULL
mutants	NULL
include	NULL
Z	NULL
(	NULL
1-25	NULL
,	NULL
89-245	NULL
)	NULL
,	NULL
which	NULL
contains	NULL
a	NULL
deletion	NULL
of	NULL
the	NULL
sequences	NULL
spanned	NULL
by	NULL
the	NULL
two	NULL
HindIII	NULL
sites	NULL
in	NULL
the	NULL
BZLFI	NULL
cDNA	NULL
,	NULL
and	NULL
Z	NULL
(	NULL
1-25	NULL
,	NULL
141-245	NULL
)	NULL
,	NULL
which	NULL
contains	NULL
a	NULL
deletion	NULL
between	NULL
the	NULL
leftmost	NULL
HindIII	NULL
site	NULL
and	NULL
the	NULL
Nhel	NULL
site	NULL
(	NULL
1	NULL
)	NULL
.	NULL

Two	NULL
mutants	NULL
with	NULL
altered	NULL
amino	NULL
acids	NULL
in	NULL
the	NULL
basic	NULL
domain	NULL
of	NULL
exon	NULL
II	NULL
,	NULL
constructed	NULL
by	NULL
oligonucleotide-mediated	NULL
mutagenesis	NULL
,	NULL
were	NULL
obtained	NULL
from	NULL
E.	NULL
Flemington	NULL
.	NULL

They	NULL
are	NULL
M178-180	NULL
,	NULL
in	NULL
which	NULL
KRY	NULL
has	NULL
been	NULL
changed	NULL
to	NULL
EEL	NULL
,	NULL
and	NULL
M187-189	NULL
,	NULL
in	NULL
which	NULL
FUNCTIONS	NULL
OF	NULL
ZEBRA	NULL
REGIONS	NULL
IN	NULL
YEAST	NULL
AND	NULL
B	NULL
CELLS	NULL
7473	NULL
RKC	NULL
has	NULL
been	NULL
altered	NULL
to	NULL
EES	NULL
.	NULL

These	NULL
mutants	NULL
do	NULL
not	NULL
bind	NULL
DNA	NULL
in	NULL
vitro	NULL
(	NULL
47	NULL
)	NULL
.	NULL

N-terminal-deletion	NULL
mutants	NULL
.	NULL

A	NULL
set	NULL
of	NULL
nested	NULL
amino-termi-nal-deletion	NULL
mutants	NULL
of	NULL
ZEBRA	NULL
was	NULL
constructed	NULL
by	NULL
the	NULL
polymerase	NULL
chain	NULL
reaction	NULL
(	NULL
PCR	NULL
)	NULL
.	NULL

The	NULL
primers	NULL
contained	NULL
,	NULL
in	NULL
5'-to0-3	NULL
'	NULL
direction	NULL
,	NULL
5°	NULL
AGATCTGCCGCCGCCATG	NULL
3	NULL
'	NULL
,	NULL
followed	NULL
by	NULL
15	NULL
nucleotides	NULL
complementary	NULL
to	NULL
the	NULL
5	NULL
boundary	NULL
of	NULL
the	NULL
deletion	NULL
end	NULL
point	NULL
.	NULL

This	NULL
primer	NULL
contains	NULL
a	NULL
Bg/l	NULL
site	NULL
,	NULL
followed	NULL
by	NULL
a	NULL
consensus	NULL
translation	NULL
enhancer	NULL
sequence	NULL
,	NULL
followed	NULL
by	NULL
a	NULL
translation	NULL
initiator	NULL
codon	NULL
.	NULL

The	NULL
mutants	NULL
began	NULL
at	NULL
aa	NULL
2	NULL
,	NULL
25	NULL
,	NULL
52	NULL
,	NULL
77	NULL
,	NULL
99	NULL
,	NULL
and	NULL
131	NULL
of	NULL
ZEBRA	NULL
.	NULL

The	NULL
primer	NULL
flanking	NULL
the	NULL
3	NULL
'	NULL
end	NULL
of	NULL
the	NULL
ZEBRA	NULL
gene	NULL
contained	NULL
a	NULL
BamHI	NULL
site	NULL
GGATCC	NULL
preceded	NULL
by	NULL
15	NULL
nucleotides	NULL
complementary	NULL
to	NULL
the	NULL
DNA	NULL
encoding	NULL
the	NULL
carboxy	NULL
terminus	NULL
of	NULL
ZEBRA	NULL
.	NULL

The	NULL
PCR	NULL
products	NULL
were	NULL
cleaved	NULL
with	NULL
Bg/ll	NULL
and	NULL
BamHI	NULL
and	NULL
inserted	NULL
into	NULL
pBXG1	NULL
cut	NULL
with	NULL
BeiII	NULL
and	NULL
BamHI	NULL
.	NULL

They	NULL
were	NULL
subcloned	NULL
into	NULL
the	NULL
yeast	NULL
vector	NULL
pBM125	NULL
.	NULL

which	NULL
was	NULL
cut	NULL
with	NULL
BamHI	NULL
and	NULL
Salil	NULL
.	NULL

The	NULL
3	NULL
``	NULL
end	NULL
of	NULL
the	NULL
ZEBRA	NULL
gene	NULL
was	NULL
a	NULL
Bg/lI-Pstl	NULL
fragment	NULL
of	NULL
the	NULL
BZLFI	NULL
cDNA	NULL
cloned	NULL
into	NULL
pBluescript	NULL
.	NULL

This	NULL
strategy	NULL
was	NULL
used	NULL
in	NULL
order	NULL
to	NULL
preserve	NULL
the	NULL
stop	NULL
codon	NULL
at	NULL
the	NULL
end	NULL
of	NULL
the	NULL
BZLFI	NULL
open	NULL
reading	NULL
frame	NULL
.	NULL

The	NULL
nucleotide	NULL
sequence	NULL
of	NULL
the	NULL
N-terminal-deletion	NULL
mutants	NULL
was	NULL
determined	NULL
in	NULL
the	NULL
yeast	NULL
plasmids	NULL
by	NULL
the	NULL
Sanger	NULL
method	NULL
.	NULL

GAL4	NULL
fusions	NULL
.	NULL

PCR	NULL
primers	NULL
for	NULL
GAL4-ZEBRA	NULL
fusion	NULL
proteins	NULL
were	NULL
either	NULL
the	NULL
same	NULL
as	NULL
those	NULL
used	NULL
in	NULL
the	NULL
ZEBRA	NULL
amino-terminal	NULL
deletions	NULL
or	NULL
new	NULL
ones	NULL
constructed	NULL
by	NULL
placing	NULL
a	NULL
BamHI	NULL
site	NULL
5	NULL
and	NULL
cither	NULL
a	NULL
BamHI	NULL
site	NULL
or	NULL
a	NULL
BefIl	NULL
site	NULL
3	NULL
'	NULL
to	NULL
the	NULL
coding	NULL
sequence	NULL
of	NULL
interest	NULL
.	NULL

These	NULL
PCR	NULL
products	NULL
were	NULL
cleaved	NULL
with	NULL
Bg/l1	NULL
and	NULL
BamHI	NULL
and	NULL
inserted	NULL
into	NULL
the	NULL
BamHI	NULL
site	NULL
of	NULL
pBXG1	NULL
,	NULL
which	NULL
contains	NULL
the	NULL
simian	NULL
virus	NULL
40	NULL
enhancer	NULL
driving	NULL
expression	NULL
of	NULL
DNA	NULL
encoding	NULL
aa	NULL
1	NULL
to	NULL
147	NULL
of	NULL
GAL4	NULL
[	NULL
GALA	NULL
(	NULL
I-147	NULL
)	NULL
]	NULL
(	NULL
41	NULL
)	NULL
.	NULL

This	NULL
created	NULL
an	NULL
in-frame	NULL
fusion	NULL
with	NULL
the	NULL
DNA	NULL
binding	NULL
domain	NULL
of	NULL
GAL4	NULL
.	NULL

The	NULL
GAL4-ZEBRA	NULL
fusions	NULL
were	NULL
then	NULL
subcloned	NULL
into	NULL
two	NULL
yeast	NULL
expression	NULL
vectors	NULL
.	NULL

pMA424	NULL
and	NULL
pGG29	NULL
.	NULL

pMA424	NULL
is	NULL
a	NULL
2m	NULL
plasmid	NULL
in	NULL
which	NULL
GAL4	NULL
(	NULL
1-147	NULL
)	NULL
is	NULL
driven	NULL
by	NULL
the	NULL
ADH	NULL
1T	NULL
promoter	NULL
(	NULL
30	NULL
)	NULL
.	NULL

pGG29	NULL
is	NULL
an	NULL
ARSI	NULL
CEN3	NULL
plasmid	NULL
which	NULL
contains	NULL
GAL4	NULL
(	NULL
1-147	NULL
)	NULL
driven	NULL
by	NULL
the	NULL
GAL4	NULL
promoter	NULL
,	NULL
a	NULL
gift	NULL
from	NULL
Grace	NULL
Gill	NULL
,	NULL
Department	NULL
of	NULL
Biochemistry	NULL
,	NULL
University	NULL
of	NULL
California	NULL
at	NULL
Berkeley	NULL
.	NULL

The	NULL
junction	NULL
between	NULL
GAL4	NULL
(	NULL
1-147	NULL
)	NULL
and	NULL
ZEBRA	NULL
was	NULL
sequenced	NULL
.	NULL

B-Galactosidase	NULL
assays	NULL
.	NULL

S.	NULL
cerevisiae	NULL
was	NULL
transformed	NULL
by	NULL
a	NULL
lithium	NULL
acetate	NULL
method	NULL
with	NULL
5	NULL
ul	NULL
of	NULL
Escherichia	NULL
coli	NULL
minilysate	NULL
plasmid	NULL
DNA	NULL
plus	NULL
50	NULL
ug	NULL
of	NULL
calf	NULL
thymus	NULL
DNA	NULL
as	NULL
the	NULL
carrier	NULL
(	NULL
21	NULL
)	NULL
.	NULL

Yeast	NULL
cells	NULL
were	NULL
plated	NULL
onto	NULL
a	NULL
nitrocellulose	NULL
filter	NULL
placed	NULL
on	NULL
the	NULL
appropriate	NULL
synthetic	NULL
complete	NULL
(	NULL
SC	NULL
)	NULL
yeast	NULL
medium	NULL
drop-out	NULL
plates	NULL
containing	NULL
2	NULL
%	NULL
glucose	NULL
.	NULL

After	NULL
the	NULL
colonies	NULL
were	NULL
visible	NULL
(	NULL
after	NULL
about	NULL
48	NULL
h	NULL
)	NULL
,	NULL
the	NULL
filters	NULL
were	NULL
transferred	NULL
to	NULL
X-Gal	NULL
(	NULL
5-bromo-4-chloro-3-indolyl-B-	NULL
»	NULL
-galactopyranoside	NULL
)	NULL
indicator	NULL
medium	NULL
drop-out	NULL
plates	NULL
containing	NULL
2	NULL
%	NULL
galactose	NULL
(	NULL
43	NULL
)	NULL
.	NULL

The	NULL
extent	NULL
of	NULL
activation	NULL
of	NULL
LacZ	NULL
was	NULL
scored	NULL
qualitatively	NULL
by	NULL
inspection	NULL
of	NULL
the	NULL
X-Gal	NULL
plates	NULL
.	NULL

Individual	NULL
representative	NULL
colonies	NULL
were	NULL
subcultured	NULL
from	NULL
the	NULL
X-Gal	NULL
plate	NULL
to	NULL
a	NULL
liquid	NULL
SC	NULL
drop-out	NULL
culture	NULL
containing	NULL
2	NULL
%	NULL
glucose	NULL
.	NULL

After	NULL
overnight	NULL
incubation	NULL
,	NULL
the	NULL
cultures	NULL
were	NULL
washed	NULL
once	NULL
with	NULL
SC	NULL
and	NULL
resuspended	NULL
in	NULL
drop-out	NULL
medium	NULL
containing	NULL
2	NULL
%	NULL
galactose	NULL
.	NULL

These	NULL
cultures	NULL
were	NULL
further	NULL
incubated	NULL
overnight	NULL
and	NULL
were	NULL
harvested	NULL
for	NULL
B-galactosidase	NULL
assay	NULL
.	NULL

The	NULL
cells	NULL
were	NULL
fractured	NULL
by	NULL
vortexing	NULL
with	NULL
glass	NULL
beads	NULL
.	NULL

The	NULL
level	NULL
of	NULL
B-galactosidase	NULL
activity	NULL
was	NULL
measured	NULL
as	NULL
described	NULL
elsewhere	NULL
(	NULL
18	NULL
)	NULL
,	NULL
and	NULL
the	NULL
protein	NULL
content	NULL
was	NULL
determined	NULL
by	NULL
using	NULL
a	NULL
Bio-Rad	NULL
protein	NULL
determination	NULL
kit	NULL
.	NULL

B-Galactosidase	NULL
activity	NULL
was	NULL
calculated	NULL
as	NULL
1,000	NULL
x	NULL
the	NULL
optical	NULL
density	NULL
at	NULL
420	NULL
nm/time	NULL
(	NULL
minutes	NULL
)	NULL
x	NULL
the	NULL
optical	NULL
density	NULL
at	NULL
595	NULL
nm	NULL
X	NULL
volume	NULL
(	NULL
milliliters	NULL
)	NULL
.	NULL

Human	NULL
B-cell	NULL
transfections	NULL
.	NULL

Transcriptional	NULL
activation	NULL
by	NULL
ZEBRA	NULL
and	NULL
ZEBRA	NULL
deletion	NULL
mutants	NULL
was	NULL
assayed	NULL
in	NULL
the	NULL
EBV-negative	NULL
human	NULL
B-cell	NULL
line	NULL
BJAB	NULL
.	NULL

The	NULL
internal-deletion	NULL
7474	NULL
MILLER	NULL
ET	NULL
AL	NULL
.	NULL

J.	NULL
Viror	NULL
.	NULL

Reporter	NULL
(	NULL
CZA	NULL
)	NULL
TA'TA	NULL
A.	NULL
I	NULL
T	NULL
Xbal	NULL
43bp	NULL
15bp	NULL
129bp	NULL
MCS	NULL
CYC	NULL
1	NULL
LAC	NULL
Z	NULL
Activator	NULL
(	NULL
pBM125	NULL
)	NULL
(	NULL
BZLF1	NULL
)	NULL
850bp	NULL
275b	NULL
I	NULL
I	NULL
EcoRI	NULL
BamHI	NULL
-	NULL
Sall	NULL
GAL1/10	NULL
pBR	NULL
LEUZ2	NULL
exon	NULL
I	NULL
exon	NULL
II	NULL
exon	NULL
II	NULL
|_	NULL
§	NULL
3	NULL
a	NULL
do	NULL
G4	NULL
§04	NULL
[	NULL
go	NULL
g	NULL
£1	NULL
)	NULL
f	NULL
C.	NULL
1	NULL
2	NULL
E	NULL
3	NULL
10	NULL
1	NULL
$	NULL
1	NULL
|	NULL
-	NULL
C	NULL
T	NULL
C	NULL
1Do-T	NULL
A	NULL
H	NULL
+	NULL
J	NULL
1	NULL
_|	NULL
J	NULL
ZEBRA	NULL
|	NULL
167	NULL
aa	NULL
[	NULL
35	NULL
aa	NULL
]	NULL
43	NULL
aa	NULL
|	NULL
activation	NULL
DNA	NULL
_	NULL
dimerization	NULL
recognition	NULL
Clone	NULL
Z	NULL
(	NULL
1-245	NULL
)	NULL
Z	NULL
(	NULL
1-227	NULL
)	NULL
+	NULL
VP16	NULL
0	NULL
40	NULL
80	NULL
120	NULL
160	NULL
200	NULL
240	NULL
280	NULL
320	NULL
Amino	NULL
Acids	NULL
[	NULL
L_	NULL
]	NULL
ZEBRA	NULL
as	NULL
vas	NULL
D.	NULL
4.0-	NULL
[	NULL
CBM1i25	NULL
RRz	NULL
(	NULL
1-227	NULL
)	NULL
+	NULL
vPi16	NULL
&	NULL
(	NULL
+	NULL
]	NULL
o	NULL
0	NULL
Beta	NULL
Galactosidase	NULL
Units	NULL
(	NULL
Logg	NULL
)	NULL
1.0	NULL
Reporter	NULL
CZA	NULL
Z1/CZ	NULL
Z3/0Z	NULL
Z5/CZ	NULL
Z7/CZ	NULL
Stimulation	NULL
1.0	NULL
04	NULL
0.5	NULL
1.0	NULL
4.3	NULL
19.4	NULL
1.0	NULL
32.4168.4	NULL
1.0	NULL
11.7	NULL
89.2	NULL
1.0	NULL
3.9	NULL
19.5	NULL
Vou	NULL
.	NULL

67	NULL
,	NULL
1993	NULL
FUNCTIONS	NULL
OF	NULL
ZEBRA	NULL
REGIONS	NULL
IN	NULL
YEAST	NULL
AND	NULL
B	NULL
CELLS	NULL
7475	NULL
FIG	NULL
.	NULL

1	NULL
.	NULL

Activation	NULL
of	NULL
transcription	NULL
by	NULL
ZEBRA	NULL
in	NULL
S.	NULL
cerevisiae	NULL
.	NULL

(	NULL
A	NULL
)	NULL
Reporter	NULL
plasmids	NULL
.	NULL

Different	NULL
numbers	NULL
of	NULL
oligomerized	NULL
ZIIIB	NULL
sites	NULL
[	NULL
(	NULL
ZIIIB	NULL
)	NULL
n	NULL
]	NULL
,	NULL
to	NULL
which	NULL
ZEBRA	NULL
binds	NULL
,	NULL
were	NULL
cloned	NULL
into	NULL
an	NULL
Xbal	NULL
site	NULL
in	NULL
a	NULL
multiple-cloning	NULL
site	NULL
(	NULL
MCS	NULL
)	NULL
in	NULL
the	NULL
vector	NULL
pCZA	NULL
(	NULL
29	NULL
)	NULL
.	NULL

As	NULL
a	NULL
control	NULL
,	NULL
a	NULL
700-bp	NULL
fragment	NULL
containing	NULL
oriP	NULL
,	NULL
to	NULL
which	NULL
ZEBRA	NULL
does	NULL
not	NULL
bind	NULL
,	NULL
was	NULL
placed	NULL
in	NULL
the	NULL
MCS	NULL
in	NULL
pCZA	NULL
.	NULL

The	NULL
reporter	NULL
contains	NULL
a	NULL
144-bp	NULL
minimal	NULL
promoter	NULL
from	NULL
the	NULL
yeast	NULL
CYCI	NULL
gene	NULL
upstream	NULL
of	NULL
lacZ	NULL
.	NULL

(	NULL
B	NULL
)	NULL
Activator	NULL
plasmids	NULL
.	NULL

Derivatives	NULL
of	NULL
a	NULL
cDNA	NULL
of	NULL
the	NULL
BZLFI1	NULL
gene	NULL
encoding	NULL
ZEBRA	NULL
were	NULL
cloned	NULL
as	NULL
BamHI	NULL
or	NULL
BamHI-Sall	NULL
fragments	NULL
downstream	NULL
of	NULL
the	NULL
850-bp	NULL
GAL	NULL
I-GAL10	NULL
(	NULL
GAL1/10	NULL
)	NULL
promoter	NULL
in	NULL
the	NULL
plasmid	NULL
pBM125	NULL
.	NULL

(	NULL
C	NULL
)	NULL
Two	NULL
activator	NULL
plasmids	NULL
which	NULL
contain	NULL
ZEBRA	NULL
.	NULL

The	NULL
top	NULL
line	NULL
shows	NULL
the	NULL
approximate	NULL
location	NULL
of	NULL
the	NULL
activating	NULL
,	NULL
DNA	NULL
recognition	NULL
,	NULL
and	NULL
dimerization	NULL
regions	NULL
of	NULL
ZEBRA	NULL
.	NULL

Restriction	NULL
endonuclease	NULL
recognition	NULL
sites	NULL
used	NULL
for	NULL
preparation	NULL
of	NULL
internal-deletion	NULL
mutants	NULL
(	NULL
see	NULL
Fig	NULL
.	NULL

2B	NULL
)	NULL
and	NULL
ZEBRA-VP16	NULL
fusions	NULL
are	NULL
shown	NULL
.	NULL

Z	NULL
(	NULL
1-245	NULL
)	NULL
is	NULL
an	NULL
intact	NULL
BZLF1	NULL
cDNA	NULL
.	NULL

Z	NULL
(	NULL
1-227	NULL
)	NULL
+	NULL
VP16	NULL
has	NULL
the	NULL
carboxy-terminal	NULL
18	NULL
aa	NULL
of	NULL
ZEBRA	NULL
removed	NULL
and	NULL
replaced	NULL
with	NULL
aa	NULL
411	NULL
to	NULL
490	NULL
of	NULL
VP16	NULL
(	NULL
1	NULL
)	NULL
.	NULL

(	NULL
D	NULL
)	NULL
Data	NULL
from	NULL
a	NULL
representative	NULL
experiment	NULL
.	NULL

Yeast	NULL
strain	NULL
W3031A	NULL
was	NULL
cotransfected	NULL
with	NULL
one	NULL
activator	NULL
plasmid	NULL
and	NULL
one	NULL
reporter	NULL
plasmid	NULL
.	NULL

The	NULL
activator	NULL
was	NULL
Z	NULL
(	NULL
1-245	NULL
)	NULL
or	NULL
Z	NULL
(	NULL
1-227	NULL
)	NULL
+VP16	NULL
or	NULL
,	NULL
as	NULL
a	NULL
negative	NULL
control	NULL
,	NULL
the	NULL
pBM125	NULL
vector	NULL
.	NULL

The	NULL
reporters	NULL
were	NULL
derivatives	NULL
of	NULL
pCZA	NULL
containing	NULL
no	NULL
ZIIIB	NULL
elements	NULL
or	NULL
one	NULL
,	NULL
three	NULL
,	NULL
five	NULL
,	NULL
or	NULL
seven	NULL
ZIIIB	NULL
elements	NULL
upstream	NULL
of	NULL
the	NULL
minimal	NULL
CYC7	NULL
promoter	NULL
fused	NULL
to	NULL
lacZ	NULL
.	NULL

Stimulation	NULL
is	NULL
calculated	NULL
as	NULL
the	NULL
ratio	NULL
of	NULL
B-galactosidase	NULL
units	NULL
expressed	NULL
from	NULL
a	NULL
reporter	NULL
after	NULL
exposure	NULL
to	NULL
an	NULL
activator	NULL
to	NULL
the	NULL
number	NULL
of	NULL
B-galactosidase	NULL
units	NULL
expressed	NULL
from	NULL
the	NULL
same	NULL
reporter	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
the	NULL
vector	NULL
pBM125	NULL
.	NULL

and	NULL
C-terminal-deletion	NULL
mutant	NULL
activators	NULL
were	NULL
cloned	NULL
in	NULL
pHD1013	NULL
,	NULL
which	NULL
contains	NULL
the	NULL
cytomegalovirus	NULL
promoter-enhancer	NULL
(	NULL
8	NULL
)	NULL
.	NULL

The	NULL
N-terminal-deletion	NULL
mutant	NULL
activators	NULL
were	NULL
cloned	NULL
downstream	NULL
of	NULL
the	NULL
simian	NULL
virus	NULL
40	NULL
promoter-enhancer	NULL
in	NULL
pBXG1	NULL
,	NULL
a	NULL
gift	NULL
from	NULL
P.	NULL
Broad	NULL
(	NULL
41	NULL
)	NULL
.	NULL

The	NULL
reporter	NULL
was	NULL
Z3EA4CAT	NULL
,	NULL
in	NULL
which	NULL
three	NULL
oligomerized	NULL
ZIIIB	NULL
sites	NULL
were	NULL
inserted	NULL
upstream	NULL
of	NULL
the	NULL
minimal	NULL
adenovirus	NULL
E4	NULL
promoter	NULL
,	NULL
fused	NULL
to	NULL
chloramphenicol	NULL
acetyltransferase	NULL
(	NULL
CAT	NULL
)	NULL
(	NULL
4	NULL
,	NULL
16	NULL
)	NULL
.	NULL

Cells	NULL
were	NULL
transfected	NULL
by	NULL
electroporation	NULL
with	NULL
10	NULL
ug	NULL
of	NULL
activator	NULL
and	NULL
10	NULL
pg	NULL
of	NULL
reporter	NULL
.	NULL

CAT	NULL
assays	NULL
were	NULL
performed	NULL
with	NULL
30	NULL
pl	NULL
of	NULL
cell	NULL
extract	NULL
prepared	NULL
48	NULL
h	NULL
after	NULL
transfection	NULL
.	NULL

Proteins	NULL
were	NULL
detected	NULL
by	NULL
immunoblotting	NULL
with	NULL
polyvalent	NULL
rabbit	NULL
anti-sera	NULL
to	NULL
ZEBRA	NULL
.	NULL

RESULTS	NULL
Experimental	NULL
design	NULL
.	NULL

The	NULL
capacity	NULL
of	NULL
ZEBRA	NULL
to	NULL
activate	NULL
transcription	NULL
in	NULL
S.	NULL
cerevisiae	NULL
was	NULL
examined	NULL
in	NULL
two	NULL
types	NULL
of	NULL
experiments	NULL
.	NULL

In	NULL
one	NULL
type	NULL
,	NULL
activators	NULL
were	NULL
expressed	NULL
from	NULL
plasmid	NULL
constructs	NULL
encoding	NULL
the	NULL
native	NULL
DNA	NULL
binding	NULL
and	NULL
dimerization	NULL
domains	NULL
of	NULL
ZEBRA	NULL
itself	NULL
(	NULL
aa	NULL
167	NULL
to	NULL
227	NULL
)	NULL
together	NULL
with	NULL
various	NULL
portions	NULL
of	NULL
the	NULL
remainder	NULL
of	NULL
the	NULL
ZEBRA	NULL
protein	NULL
(	NULL
Fig	NULL
.	NULL

1C	NULL
)	NULL
.	NULL

In	NULL
these	NULL
experiments	NULL
,	NULL
transcription	NULL
was	NULL
measured	NULL
from	NULL
reporter	NULL
genes	NULL
containing	NULL
one	NULL
,	NULL
three	NULL
,	NULL
five	NULL
,	NULL
or	NULL
seven	NULL
oligomerized	NULL
ZIIIB	NULL
ZREs	NULL
upstream	NULL
of	NULL
a	NULL
CYC	NULL
!	NULL

-lacZ	NULL
fusion	NULL
.	NULL

In	NULL
the	NULL
other	NULL
set	NULL
of	NULL
experiments	NULL
,	NULL
the	NULL
activators	NULL
consisted	NULL
of	NULL
ZEBRA	NULL
,	NULL
or	NULL
portions	NULL
thereof	NULL
,	NULL
fused	NULL
to	NULL
the	NULL
DNA	NULL
binding	NULL
domain	NULL
(	NULL
aa	NULL
1	NULL
to	NULL
147	NULL
)	NULL
of	NULL
the	NULL
yeast	NULL
activator	NULL
,	NULL
GAL4	NULL
.	NULL

Reporter	NULL
genes	NULL
contained	NULL
GAL4	NULL
binding	NULL
sites	NULL
upstream	NULL
of	NULL
a	NULL
minimal	NULL
promoter	NULL
(	NULL
CYC	NULL
)	NULL
or	NULL
GAL1	NULL
)	NULL
fused	NULL
to	NULL
lacZ	NULL
.	NULL

In	NULL
both	NULL
types	NULL
of	NULL
experiments	NULL
,	NULL
B-galactosidase	NULL
activity	NULL
served	NULL
as	NULL
a	NULL
measure	NULL
of	NULL
transcription	NULL
.	NULL

The	NULL
ZEBRA	NULL
deletion	NULL
mutants	NULL
were	NULL
also	NULL
examined	NULL
for	NULL
their	NULL
capacity	NULL
to	NULL
activate	NULL
transcription	NULL
in	NULL
an	NULL
EBV-negative	NULL
human	NULL
B-lymphocyte	NULL
cell	NULL
line	NULL
.	NULL

The	NULL
reporter	NULL
used	NULL
in	NULL
B	NULL
cells	NULL
contained	NULL
three	NULL
oligomerized	NULL
ZIIIB	NULL
sites	NULL
upstream	NULL
of	NULL
a	NULL
minimal	NULL
adenovirus	NULL
E4	NULL
gene	NULL
promoter	NULL
fused	NULL
to	NULL
the	NULL
CAT	NULL
gene	NULL
(	NULL
4	NULL
,	NULL
16	NULL
)	NULL
.	NULL

CAT	NULL
activity	NULL
served	NULL
as	NULL
a	NULL
measure	NULL
of	NULL
transcription	NULL
.	NULL

ZEBRA	NULL
is	NULL
a	NULL
sequence-specific	NULL
activator	NULL
in	NULL
S.	NULL
cerevisiae	NULL
.	NULL

As	NULL
shown	NULL
in	NULL
Fig	NULL
.	NULL

1D	NULL
,	NULL
ZEBRA	NULL
activated	NULL
transcription	NULL
in	NULL
S.	NULL
cerevisige	NULL
from	NULL
reporter	NULL
genes	NULL
bearing	NULL
one	NULL
or	NULL
more	NULL
ZREs	NULL
.	NULL

ZEBRA	NULL
failed	NULL
to	NULL
activate	NULL
transcription	NULL
from	NULL
a	NULL
reporter	NULL
gene	NULL
lacking	NULL
ZEBRA	NULL
binding	NULL
sites	NULL
(	NULL
pCZA	NULL
)	NULL
or	NULL
from	NULL
a	NULL
reporter	NULL
gene	NULL
containing	NULL
20	NULL
copies	NULL
of	NULL
a	NULL
30-bp	NULL
repeat	NULL
from	NULL
the	NULL
EBV	NULL
latent	NULL
origin	NULL
of	NULL
replication	NULL
(	NULL
oriP	NULL
)	NULL
to	NULL
which	NULL
the	NULL
EBV	NULL
protein	NULL
EBNA-1	NULL
binds	NULL
but	NULL
to	NULL
which	NULL
ZEBRA	NULL
does	NULL
not	NULL
bind	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

The	NULL
capacity	NULL
of	NULL
ZEBRA	NULL
to	NULL
activate	NULL
transcription	NULL
from	NULL
reporters	NULL
bearing	NULL
single	NULL
or	NULL
multiple	NULL
ZIIIB	NULL
ZREs	NULL
was	NULL
eliminated	NULL
by	NULL
mutations	NULL
which	NULL
destroyed	NULL
the	NULL
ability	NULL
of	NULL
ZEBRA	NULL
to	NULL
bind	NULL
to	NULL
DNA	NULL
.	NULL

Mutants	NULL
Z	NULL
(	NULL
M178-180	NULL
)	NULL
and	NULL
Z	NULL
(	NULL
M187-189	NULL
)	NULL
,	NULL
in	NULL
which	NULL
basic	NULL
amino	NULL
acids	NULL
required	NULL
for	NULL
DNA	NULL
binding	NULL
are	NULL
changed	NULL
to	NULL
acidic	NULL
ones	NULL
,	NULL
no	NULL
longer	NULL
activated	NULL
transcription	NULL
from	NULL
reporters	NULL
containing	NULL
oligomerized	NULL
ZREs	NULL
(	NULL
Fig	NULL
.	NULL

2B	NULL
and	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

Fig	NULL
.	NULL

1D	NULL
shows	NULL
that	NULL
ZEBRA	NULL
was	NULL
a	NULL
weak	NULL
activator	NULL
in	NULL
S.	NULL
cerevisiae	NULL
.	NULL

Addition	NULL
of	NULL
the	NULL
VP16	NULL
activation	NULL
domain	NULL
to	NULL
ZEBRA	NULL
in	NULL
the	NULL
mutant	NULL
Z	NULL
(	NULL
1-227	NULL
)	NULL
+VP16	NULL
created	NULL
an	NULL
activator	NULL
fivefold	NULL
more	NULL
potent	NULL
than	NULL
wild-type	NULL
ZEBRA	NULL
.	NULL

As	NULL
is	NULL
characteristic	NULL
of	NULL
many	NULL
weak	NULL
eukaryotic	NULL
activators	NULL
,	NULL
ZEBRA	NULL
activated	NULL
transcription	NULL
in	NULL
a	NULL
synergistic	NULL
fashion	NULL
(	NULL
4	NULL
)	NULL
.	NULL

In	NULL
S.	NULL
cerevisiae	NULL
,	NULL
ZEBRA	NULL
only	NULL
weakly	NULL
activated	NULL
(	NULL
4-fold	NULL
)	NULL
transcription	NULL
from	NULL
a	NULL
reporter	NULL
with	NULL
one	NULL
ZIIIB	NULL
site	NULL
and	NULL
maximally	NULL
stimulated	NULL
(	NULL
32-fold	NULL
in	NULL
the	NULL
experiment	NULL
illustrated	NULL
)	NULL
transcription	NULL
from	NULL
reporters	NULL
containing	NULL
three	NULL
tandem	NULL
ZIIIB	NULL
sites	NULL
.	NULL

The	NULL
stimulation	NULL
of	NULL
transcription	NULL
on	NULL
ZEBRA	NULL
Amino	NULL
Acids	NULL
B-Galactosidase	NULL
Units	NULL
Simulation	NULL
as	NULL
50	NULL
Ts	NULL
100	NULL
125	NULL
150	NULL
175200	NULL
225250	NULL
ois	NULL
?	NULL

_	NULL
500	NULL
___	NULL
1000___	NULL
1500	NULL
Z	NULL
(	NULL
2-245	NULL
)	NULL
11.6	NULL
2	NULL
(	NULL
25-245	NULL
)	NULL
54	NULL
Z	NULL
(	NULL
51-245	NULL
)	NULL
5.6	NULL
Z	NULL
(	NULL
77-245	NULL
)	NULL
28	NULL
288-245	NULL
)	NULL
25	NULL
2	NULL
(	NULL
09-245	NULL
)	NULL
2	NULL
(	NULL
131-245	NULL
)	NULL
Reporter	NULL
:	NULL
Z3/CZ	NULL
B-Galactosidase	NULL
Units	NULL
Stimulation	NULL
ZEBRA	NULL
Amino	NULL
Acids	NULL
ind	NULL
B	NULL
0137	NULL
__	NULL
soo	NULL
1000	NULL
__	NULL
ts00	NULL
___2000	NULL
.	NULL

.	NULL

``	NULL
``	NULL
4°®	NULL
125	NULL
175	NULL
200	NULL
2	NULL
(	NULL
1-245	NULL
)	NULL
13.7	NULL
2	NULL
(	NULL
1-25,80-245	NULL
)	NULL
Z	NULL
(	NULL
1-25,141-245	NULL
)	NULL
2	NULL
(	NULL
1-25,141-227	NULL
)	NULL
2	NULL
(	NULL
1-227	NULL
)	NULL
Z	NULL
(	NULL
M178-180	NULL
)	NULL
2Z	NULL
(	NULL
M187-189	NULL
)	NULL
Reporter	NULL
:	NULL
Z8/C2	NULL
FIG	NULL
.	NULL

2	NULL
.	NULL

Activation	NULL
of	NULL
transcription	NULL
by	NULL
ZEBRA	NULL
N-terminal-deletion	NULL
mutants	NULL
(	NULL
A	NULL
)	NULL
and	NULL
internal-deletion	NULL
and	NULL
point	NULL
mutants	NULL
(	NULL
B	NULL
)	NULL
in	NULL
S.	NULL
cerevi-sige	NULL
.	NULL

The	NULL
data	NULL
are	NULL
averages	NULL
for	NULL
duplicate	NULL
experiments	NULL
with	NULL
each	NULL
set	NULL
of	NULL
mutants	NULL
.	NULL

The	NULL
experiments	NULL
were	NULL
conducted	NULL
in	NULL
yeast	NULL
strain	NULL
W3031A	NULL
.	NULL

The	NULL
vertical	NULL
lines	NULL
represent	NULL
the	NULL
level	NULL
of	NULL
B-galactosidase	NULL
activity	NULL
(	NULL
137	NULL
units	NULL
)	NULL
as	NULL
a	NULL
measure	NULL
of	NULL
background	NULL
transcription	NULL
from	NULL
the	NULL
Z3/CZ	NULL
reporter	NULL
(	NULL
a	NULL
derivative	NULL
of	NULL
pCZA	NULL
containing	NULL
three	NULL
oligomerized	NULL
ZIIIB	NULL
sites	NULL
)	NULL
cotransfected	NULL
with	NULL
the	NULL
pBM125	NULL
vector	NULL
.	NULL

The	NULL
stimulation	NULL
index	NULL
is	NULL
the	NULL
ratio	NULL
of	NULL
B-galactosidase	NULL
units	NULL
measured	NULL
in	NULL
yeast	NULL
cells	NULL
carrying	NULL
an	NULL
activator	NULL
to	NULL
those	NULL
measured	NULL
in	NULL
yeast	NULL
cells	NULL
carrying	NULL
the	NULL
vector	NULL
pBM125	NULL
.	NULL

7476	NULL
MILLER	NULL
ET	NULL
AL	NULL
.	NULL

three	NULL
adjacent	NULL
sites	NULL
was	NULL
8-fold	NULL
that	NULL
on	NULL
one	NULL
site	NULL
;	NULL
this	NULL
is	NULL
2.5-fold	NULL
synergy	NULL
,	NULL
comparing	NULL
three	NULL
sites	NULL
with	NULL
one	NULL
site	NULL
.	NULL

The	NULL
background	NULL
level	NULL
of	NULL
transcription	NULL
measured	NULL
in	NULL
the	NULL
absence	NULL
of	NULL
an	NULL
activator	NULL
increased	NULL
when	NULL
reporters	NULL
contained	NULL
five	NULL
or	NULL
seven	NULL
oligomerized	NULL
ZIIIB	NULL
sites	NULL
(	NULL
Fig	NULL
.	NULL

1D	NULL
)	NULL
.	NULL

This	NULL
high	NULL
background	NULL
level	NULL
of	NULL
transcription	NULL
,	NULL
which	NULL
was	NULL
not	NULL
observed	NULL
from	NULL
the	NULL
reporter	NULL
bearing	NULL
20	NULL
copies	NULL
of	NULL
the	NULL
30-bp	NULL
repeat	NULL
elements	NULL
from	NULL
oriP	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
,	NULL
is	NULL
presumably	NULL
due	NULL
to	NULL
the	NULL
action	NULL
of	NULL
a	NULL
yeast	NULL
factor	NULL
which	NULL
recognizes	NULL
the	NULL
oligomerized	NULL
ZIIB	NULL
sites	NULL
and	NULL
whose	NULL
activity	NULL
required	NULL
a	NULL
high	NULL
degree	NULL
of	NULL
synergy	NULL
.	NULL

An	NULL
N-terminal	NULL
and	NULL
a	NULL
C-terminal	NULL
region	NULL
of	NULL
ZEBRA	NULL
are	NULL
required	NULL
for	NULL
activation	NULL
of	NULL
transcription	NULL
in	NULL
S.	NULL
cerevisiae	NULL
.	NULL

The	NULL
deletion	NULL
mutants	NULL
illustrated	NULL
in	NULL
Fig	NULL
.	NULL

2	NULL
defined	NULL
two	NULL
separate	NULL
regions	NULL
of	NULL
ZEBRA	NULL
protein	NULL
which	NULL
were	NULL
required	NULL
for	NULL
activation	NULL
of	NULL
transcription	NULL
in	NULL
S.	NULL
cerevisiae	NULL
.	NULL

One	NULL
region	NULL
was	NULL
the	NULL
amino-terminal	NULL
98	NULL
aa	NULL
,	NULL
and	NULL
the	NULL
other	NULL
was	NULL
the	NULL
carboxy-terminal	NULL
18	NULL
aa	NULL
.	NULL

A	NULL
nested	NULL
set	NULL
of	NULL
deletion	NULL
mutants	NULL
of	NULL
increasing	NULL
size	NULL
from	NULL
the	NULL
amino	NULL
terminus	NULL
showed	NULL
a	NULL
progressive	NULL
decrease	NULL
in	NULL
activity	NULL
(	NULL
Fig	NULL
.	NULL

2A	NULL
)	NULL
.	NULL

There	NULL
was	NULL
greater-than-50	NULL
%	NULL
reduction	NULL
of	NULL
activity	NULL
following	NULL
removal	NULL
of	NULL
the	NULL
N-terminal	NULL
24	NULL
aa	NULL
.	NULL

Removal	NULL
of	NULL
the	NULL
N-terminal	NULL
76	NULL
aa	NULL
caused	NULL
a	NULL
76	NULL
%	NULL
reduction	NULL
of	NULL
activity	NULL
,	NULL
and	NULL
removal	NULL
of	NULL
the	NULL
N-terminal	NULL
98	NULL
or	NULL
130	NULL
aa	NULL
eliminated	NULL
the	NULL
capacity	NULL
of	NULL
the	NULL
protein	NULL
to	NULL
activate	NULL
transcription	NULL
.	NULL

Deletion	NULL
of	NULL
the	NULL
second	NULL
required	NULL
region	NULL
,	NULL
located	NULL
in	NULL
the	NULL
carboxy-terminal	NULL
18	NULL
amino	NULL
acids	NULL
,	NULL
in	NULL
the	NULL
mutant	NULL
Z	NULL
(	NULL
1-227	NULL
)	NULL
reduced	NULL
the	NULL
capacity	NULL
of	NULL
the	NULL
protein	NULL
to	NULL
activate	NULL
to	NULL
less	NULL
than	NULL
20	NULL
%	NULL
of	NULL
the	NULL
wild-type	NULL
activity	NULL
(	NULL
Fig	NULL
.	NULL

2B	NULL
and	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

A	NULL
reduction	NULL
of	NULL
activity	NULL
comparable	NULL
to	NULL
that	NULL
measured	NULL
on	NULL
reporters	NULL
with	NULL
three	NULL
oligomerized	NULL
ZIIIB	NULL
sites	NULL
was	NULL
observed	NULL
on	NULL
reporters	NULL
containing	NULL
five	NULL
or	NULL
seven	NULL
oligomerized	NULL
ZIIIB	NULL
sites	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

Immunoprecipitation	NULL
experiments	NULL
showed	NULL
that	NULL
Z	NULL
(	NULL
1-227	NULL
)	NULL
was	NULL
synthesized	NULL
at	NULL
the	NULL
same	NULL
level	NULL
as	NULL
Z	NULL
(	NULL
1-245	NULL
)	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

We	NULL
observed	NULL
a	NULL
modest	NULL
decrease	NULL
in	NULL
activation	NULL
potency	NULL
in	NULL
internal-deletion	NULL
mutants	NULL
from	NULL
which	NULL
aa	NULL
26	NULL
to	NULL
140	NULL
were	NULL
removed	NULL
.	NULL

Thus	NULL
the	NULL
mutant	NULL
Z	NULL
(	NULL
1-25	NULL
,	NULL
89-245	NULL
)	NULL
was	NULL
85	NULL
%	NULL
as	NULL
active	NULL
as	NULL
the	NULL
wild	NULL
type	NULL
,	NULL
and	NULL
the	NULL
mutant	NULL
Z	NULL
(	NULL
1-25	NULL
,	NULL
141-245	NULL
)	NULL
was	NULL
78	NULL
%	NULL
as	NULL
active	NULL
as	NULL
the	NULL
wild	NULL
type	NULL
(	NULL
Fig	NULL
.	NULL

2B	NULL
)	NULL
.	NULL

If	NULL
,	NULL
however	NULL
,	NULL
these	NULL
internal	NULL
deletions	NULL
were	NULL
combined	NULL
with	NULL
deletion	NULL
of	NULL
the	NULL
C-terminal	NULL
18	NULL
aa	NULL
,	NULL
as	NULL
in	NULL
the	NULL
mutant	NULL
Z	NULL
(	NULL
1-26	NULL
,	NULL
141-227	NULL
)	NULL
,	NULL
the	NULL
protein	NULL
was	NULL
inactive	NULL
.	NULL

These	NULL
data	NULL
suggested	NULL
that	NULL
the	NULL
N-terminal	NULL
25	NULL
aa	NULL
and	NULL
the	NULL
C-terminal	NULL
18	NULL
aa	NULL
of	NULL
ZEBRA	NULL
were	NULL
both	NULL
required	NULL
to	NULL
create	NULL
a	NULL
functional	NULL
activator	NULL
in	NULL
S.	NULL
cerevisice	NULL
.	NULL

The	NULL
required	NULL
C-terminal	NULL
activating	NULL
region	NULL
of	NULL
ZEBRA	NULL
could	NULL
be	NULL
replaced	NULL
by	NULL
VP16	NULL
,	NULL
as	NULL
in	NULL
the	NULL
mutant	NULL
Z	NULL
(	NULL
1-227	NULL
)	NULL
+VP16	NULL
(	NULL
Fig	NULL
.	NULL

1D	NULL
)	NULL
.	NULL

Intact	NULL
ZEBRA	NULL
and	NULL
portions	NULL
of	NULL
the	NULL
ZEBRA	NULL
protein	NULL
fused	NULL
to	NULL
the	NULL
DNA	NULL
binding	NULL
domain	NULL
of	NULL
GAL4	NULL
behave	NULL
as	NULL
activators	NULL
in	NULL
S.	NULL
cerevisiae	NULL
.	NULL

In	NULL
preliminary	NULL
experiments	NULL
,	NULL
the	NULL
entire	NULL
BZLFI	NULL
cDNA	NULL
encoding	NULL
ZEBRA	NULL
was	NULL
fused	NULL
to	NULL
GAL4	NULL
(	NULL
1-147	NULL
)	NULL
and	NULL
expressed	NULL
from	NULL
the	NULL
strong	NULL
constitutive	NULL
promoter	NULL
on	NULL
the	NULL
plasmid	NULL
pMA424	NULL
,	NULL
which	NULL
contains	NULL
a	NULL
high-copy-number	NULL
yeast	NULL
2m-plasmid	NULL
origin	NULL
of	NULL
replication	NULL
.	NULL

High-level	NULL
expression	NULL
of	NULL
ZEBRA	NULL
under	NULL
these	NULL
conditions	NULL
was	NULL
toxic	NULL
to	NULL
several	NULL
strains	NULL
of	NULL
8.	NULL
cerevisiae	NULL
,	NULL
as	NULL
evident	NULL
by	NULL
the	NULL
appearance	NULL
of	NULL
small	NULL
colonies	NULL
on	NULL
SC	NULL
glucose	NULL
plates	NULL
.	NULL

These	NULL
small	NULL
colonies	NULL
developed	NULL
a	NULL
dark	NULL
blue	NULL
color	NULL
when	NULL
transferred	NULL
to	NULL
X-Gal	NULL
plates	NULL
,	NULL
indicative	NULL
of	NULL
high-level	NULL
transcriptional	NULL
activation	NULL
.	NULL

Strain	NULL
JPY9	NULL
was	NULL
least	NULL
affected	NULL
among	NULL
several	NULL
strains	NULL
tested	NULL
.	NULL

In	NULL
this	NULL
strain	NULL
,	NULL
GAL4	NULL
(	NULL
1-147	NULL
)	NULL
-Z	NULL
(	NULL
1-245	NULL
)	NULL
activated	NULL
transcription	NULL
about	NULL
14-fold	NULL
from	NULL
GALA	NULL
binding	NULL
sites	NULL
and	NULL
about	NULL
24-fold	NULL
from	NULL
ZEBRA	NULL
binding	NULL
sites	NULL
(	NULL
Fig	NULL
.	NULL

3A	NULL
)	NULL
.	NULL

Thus	NULL
the	NULL
intact	NULL
ZEBRA	NULL
protein	NULL
fused	NULL
to	NULL
the	NULL
DNA	NULL
binding	NULL
domain	NULL
of	NULL
GAL4	NULL
behaved	NULL
in	NULL
a	NULL
manner	NULL
consistent	NULL
with	NULL
the	NULL
protein	NULL
containing	NULL
two	NULL
different	NULL
DNA	NULL
binding	NULL
domains	NULL
.	NULL

Two	NULL
constructs	NULL
containing	NULL
the	NULL
N-terminal	NULL
activating	NULL
region	NULL
of	NULL
ZEBRA	NULL
,	NULL
namely	NULL
GALA4	NULL
(	NULL
1-147	NULL
)	NULL
-Z	NULL
(	NULL
1-198	NULL
)	NULL
and	NULL
GAL4	NULL
(	NULL
1-147	NULL
)	NULL
-Z	NULL
(	NULL
1-93	NULL
)	NULL
,	NULL
both	NULL
activated	NULL
transcription	NULL
in	NULL
this	NULL
assay	NULL
.	NULL

Since	NULL
these	NULL
two	NULL
constructs	NULL
lack	NULL
J.	NULL
ViroL	NULL
.	NULL

2000	NULL
[	NULL
LT	NULL
]	NULL
yee	NULL
&	NULL
1500	NULL
WR	NULL
s	NULL
cauce	NULL
5	NULL
9	NULL
#	NULL
§	NULL
g	NULL
1000	NULL
0	NULL
o	NULL
ES	NULL
&	NULL
0	NULL
&	NULL
500	NULL
hew	NULL
0	NULL
GAL4	NULL
(	NULL
1-147	NULL
)	NULL
GALA	NULL
(	NULL
I-147	NULL
)	NULL
GALA	NULL
(	NULL
T-147	NULL
)	NULL
GALA	NULL
(	NULL
T-147	NULL
)	NULL
GALA	NULL
(	NULL
T-147	NULL
)	NULL
GAL4	NULL
(	NULL
1-147	NULL
)	NULL
ivator	NULL
+	NULL
+	NULL
+	NULL
+	NULL
+	NULL
+	NULL
+	NULL
AH	NULL
2	NULL
(	NULL
1-2451	NULL
2	NULL
(	NULL
1-198	NULL
)	NULL
201-90	NULL
)	NULL
2	NULL
(	NULL
220-245	NULL
)	NULL
2	NULL
(	NULL
51-103	NULL
)	NULL
2	NULL
(	NULL
1-227	NULL
)	NULL
Stimulation	NULL
.	NULL

1.0	NULL
.	NULL

1.0	NULL
Z	NULL
(	NULL
1-245	NULL
)	NULL
ss2	NULL
430	NULL
da7	NULL
mae	NULL
|	NULL
dre	NULL
20	NULL
|	NULL
475	NULL
37	NULL
s0	NULL
26	NULL
18	NULL
17	NULL
10	NULL
06	NULL
ZEBRA	NULL
Amino	NULL
Acids	NULL
Fused	NULL
to	NULL
Gald	NULL
(	NULL
1-147	NULL
)	NULL
$	NULL
Galactosidase	NULL
Units	NULL
(	NULL
log	NULL
10	NULL
)	NULL
Stimulation	NULL
2s	NULL
50	NULL
75	NULL
100	NULL
125	NULL
150	NULL
175	NULL
200	NULL
225	NULL
a5o	NULL
1.0	NULL
20	NULL
_	NULL
30	NULL
4.0	NULL
Index	NULL
4290	NULL
2	NULL
(	NULL
1-227	NULL
)	NULL
1	NULL
2	NULL
(	NULL
1-198	NULL
)	NULL
972	NULL
201-09	NULL
)	NULL
328	NULL
2	NULL
(	NULL
2-51	NULL
)	NULL
|	NULL
--	NULL
2	NULL
(	NULL
@	NULL
25	NULL
)	NULL
|-22551	NULL
)	NULL
|	NULL
_	NULL
--	NULL
261-103	NULL
)	NULL
261-77	NULL
)	NULL
--	NULL
2	NULL
(	NULL
77-103	NULL
)	NULL
--	NULL
2100-195	NULL
)	NULL
--	NULL
2	NULL
(	NULL
198-245	NULL
)	NULL
2	NULL
(	NULL
228-245	NULL
)	NULL
Reporter	NULL
:	NULL
3GAL/CZ	NULL
FIG	NULL
.	NULL

3	NULL
.	NULL

Activation	NULL
of	NULL
transcription	NULL
by	NULL
ZEBRA	NULL
or	NULL
portions	NULL
of	NULL
ZEBRA	NULL
fused	NULL
to	NULL
the	NULL
DNA	NULL
binding	NULL
domain	NULL
of	NULL
GAL4	NULL
.	NULL

(	NULL
A	NULL
)	NULL
Comparison	NULL
of	NULL
activation	NULL
on	NULL
GAL4	NULL
(	NULL
shaded	NULL
bars	NULL
)	NULL
and	NULL
ZEBRA	NULL
(	NULL
open	NULL
bars	NULL
)	NULL
binding	NULL
sites	NULL
.	NULL

The	NULL
data	NULL
are	NULL
pooled	NULL
from	NULL
five	NULL
experiments	NULL
.	NULL

JPY9	NULL
(	NULL
gal4A11	NULL
)	NULL
yeast	NULL
cells	NULL
were	NULL
cotransfected	NULL
with	NULL
a	NULL
GAL4-derived	NULL
activator	NULL
and	NULL
a	NULL
reporter	NULL
.	NULL

The	NULL
two	NULL
reporters	NULL
were	NULL
derivatives	NULL
of	NULL
pCZA	NULL
containing	NULL
three	NULL
oligomerized	NULL
GAL4	NULL
binding	NULL
sites	NULL
(	NULL
3GAL/CZ	NULL
)	NULL
or	NULL
three	NULL
oligomerized	NULL
ZIHB	NULL
sites	NULL
(	NULL
Z3/CZ	NULL
)	NULL
.	NULL

The	NULL
activators	NULL
consisted	NULL
of	NULL
ZEBRA	NULL
or	NULL
portions	NULL
of	NULL
ZEBRA	NULL
that	NULL
were	NULL
fused	NULL
to	NULL
the	NULL
DNA	NULL
binding	NULL
domain	NULL
of	NULL
GAL4	NULL
(	NULL
aa	NULL
1	NULL
to	NULL
147	NULL
)	NULL
in	NULL
the	NULL
plasmid	NULL
pMA424	NULL
(	NULL
30	NULL
)	NULL
.	NULL

AH	NULL
(	NULL
amphipathic	NULL
helix	NULL
)	NULL
is	NULL
an	NULL
artificial	NULL
activator	NULL
we	NULL
used	NULL
to	NULL
compare	NULL
the	NULL
relative	NULL
potencies	NULL
of	NULL
the	NULL
ZEBRA-derived	NULL
activators	NULL
(	NULL
14	NULL
)	NULL
.	NULL

Stimulation	NULL
is	NULL
the	NULL
ratio	NULL
of	NULL
B-galactosidase	NULL
units	NULL
measured	NULL
in	NULL
yeast	NULL
cells	NULL
carrying	NULL
an	NULL
activator	NULL
to	NULL
the	NULL
background	NULL
level	NULL
on	NULL
3GAL/CZ	NULL
or	NULL
Z3/CZ	NULL
induced	NULL
by	NULL
GAL4	NULL
(	NULL
1-147	NULL
)	NULL
alone	NULL
.	NULL

This	NULL
background	NULL
level	NULL
was	NULL
24	NULL
units	NULL
on	NULL
3GAL/CZ	NULL
and	NULL
10	NULL
units	NULL
on	NULL
Z3/CZ	NULL
.	NULL

(	NULL
B	NULL
)	NULL
Activation	NULL
by	NULL
GAL4	NULL
(	NULL
1-147	NULL
)	NULL
-ZEBRA	NULL
fusions	NULL
in	NULL
the	NULL
GAL11P	NULL
strain	NULL
.	NULL

Each	NULL
plasmid	NULL
containing	NULL
a	NULL
fusion	NULL
between	NULL
GAL4	NULL
(	NULL
1-147	NULL
)	NULL
and	NULL
ZEBRA	NULL
,	NULL
or	NULL
portions	NULL
of	NULL
ZEBRA	NULL
,	NULL
was	NULL
transformed	NULL
into	NULL
strain	NULL
P56	NULL
:	NULL
:171	NULL
,	NULL
which	NULL
carries	NULL
an	NULL
integrated	NULL
reporter	NULL
consisting	NULL
of	NULL
UASq	NULL
upstream	NULL
of	NULL
lacZ	NULL
(	NULL
18	NULL
,	NULL
51	NULL
)	NULL
.	NULL

The	NULL
stimulation	NULL
index	NULL
represents	NULL
the	NULL
ratio	NULL
of	NULL
B-galactosidase	NULL
activity	NULL
measured	NULL
with	NULL
the	NULL
GAL4-ZEBRA	NULL
fusion	NULL
to	NULL
the	NULL
background	NULL
level	NULL
of	NULL
B-galactosidase	NULL
activity	NULL
measured	NULL
following	NULL
transfection	NULL
of	NULL
a	NULL
plasmid	NULL
containing	NULL
GAL4	NULL
(	NULL
1-147	NULL
)	NULL
with	NULL
no	NULL
added	NULL
activating	NULL
domain	NULL
.	NULL

This	NULL
value	NULL
,	NULL
4	NULL
units	NULL
,	NULL
is	NULL
indicated	NULL
by	NULL
a	NULL
vertical	NULL
line	NULL
.	NULL

The	NULL
data	NULL
are	NULL
from	NULL
a	NULL
representative	NULL
experiment	NULL
.	NULL

Similar	NULL
results	NULL
were	NULL
obtained	NULL
in	NULL
six	NULL
replicate	NULL
experiments	NULL
.	NULL

the	NULL
ZEBRA	NULL
DNA	NULL
binding	NULL
domain	NULL
,	NULL
they	NULL
were	NULL
only	NULL
active	NULL
when	NULL
measured	NULL
on	NULL
GAL4	NULL
binding	NULL
sites	NULL
.	NULL

Weak	NULL
activation	NULL
,	NULL
about	NULL
fivefold	NULL
above	NULL
background	NULL
level	NULL
,	NULL
was	NULL
also	NULL
observed	NULL
when	NULL
the	NULL
C-terminal	NULL
18	NULL
aa	NULL
were	NULL
fused	NULL
to	NULL
GALA	NULL
.	NULL

No	NULL
activation	NULL
was	NULL
seen	NULL
when	NULL
Z	NULL
(	NULL
51-103	NULL
)	NULL
or	NULL
Z	NULL
(	NULL
1-227	NULL
)	NULL
was	NULL
fused	NULL
to	NULL
GAL4	NULL
.	NULL

None	NULL
of	NULL
the	NULL
constructs	NULL
containing	NULL
subregions	NULL
of	NULL
ZEBRA	NULL
were	NULL
toxic	NULL
in	NULL
S.	NULL
cerevisiae	NULL
.	NULL

The	NULL
results	NULL
with	NULL
the	NULL
GAL4-ZEBRA	NULL
fusions	NULL
were	NULL
consistent	NULL
with	NULL
the	NULL
analysis	NULL
with	NULL
deletion	NULL
mutants	NULL
.	NULL

The	NULL
N-terminal	NULL
93	NULL
aa	NULL
constituted	NULL
a	NULL
moderately	NULL
strong	NULL
autonomous	NULL
activating	NULL
region	NULL
Vor	NULL
.	NULL

67	NULL
,	NULL
1993	NULL
when	NULL
fused	NULL
to	NULL
a	NULL
heterologous	NULL
DNA	NULL
binding	NULL
domain	NULL
and	NULL
assayed	NULL
in	NULL
S.	NULL
cerevisiae	NULL
,	NULL
whereas	NULL
the	NULL
C-terminal	NULL
18	NULL
aa	NULL
constituted	NULL
a	NULL
weak	NULL
activating	NULL
region	NULL
on	NULL
its	NULL
own	NULL
.	NULL

Activation	NULL
by	NULL
GAL4-ZEBRA	NULL
fusions	NULL
in	NULL
a	NULL
potentiator	NULL
yeast	NULL
strain	NULL
.	NULL

Because	NULL
ZEBRA	NULL
is	NULL
a	NULL
weak	NULL
activator	NULL
in	NULL
S.	NULL
cerevisiae	NULL
,	NULL
the	NULL
intact	NULL
protein	NULL
and	NULL
subdomains	NULL
of	NULL
ZEBRA	NULL
fused	NULL
to	NULL
the	NULL
DNA	NULL
binding	NULL
domain	NULL
of	NULL
GALA	NULL
were	NULL
tested	NULL
for	NULL
their	NULL
capacity	NULL
to	NULL
activate	NULL
transcription	NULL
in	NULL
a	NULL
yeast	NULL
strain	NULL
containing	NULL
a	NULL
mutant	NULL
GAL11	NULL
allele	NULL
that	NULL
converts	NULL
weak	NULL
activating	NULL
regions	NULL
fused	NULL
to	NULL
GAL4	NULL
(	NULL
1-147	NULL
)	NULL
into	NULL
strong	NULL
activating	NULL
regions	NULL
(	NULL
18	NULL
)	NULL
.	NULL

This	NULL
mutant	NULL
GAL11	NULL
allele	NULL
is	NULL
called	NULL
GAL11P	NULL
(	NULL
potentiator	NULL
)	NULL
.	NULL

The	NULL
purpose	NULL
of	NULL
these	NULL
experiments	NULL
was	NULL
to	NULL
define	NULL
subregions	NULL
of	NULL
the	NULL
N-terminal	NULL
domain	NULL
of	NULL
ZEBRA	NULL
which	NULL
might	NULL
contribute	NULL
to	NULL
the	NULL
activating	NULL
response	NULL
.	NULL

None	NULL
of	NULL
these	NULL
subregions	NULL
was	NULL
an	NULL
activator	NULL
when	NULL
fused	NULL
to	NULL
GAL4	NULL
and	NULL
expressed	NULL
in	NULL
wild-type	NULL
yeast	NULL
strains	NULL
or	NULL
in	NULL
yeast	NULL
strains	NULL
in	NULL
which	NULL
GAL11	NULL
was	NULL
deleted	NULL
(	NULL
Fig	NULL
.	NULL

3A	NULL
and	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

To	NULL
alleviate	NULL
toxicity	NULL
due	NULL
to	NULL
overexpression	NULL
,	NULL
and	NULL
thereby	NULL
to	NULL
increase	NULL
the	NULL
sensitivity	NULL
of	NULL
the	NULL
assay	NULL
for	NULL
activation	NULL
domains	NULL
of	NULL
ZEBRA	NULL
,	NULL
the	NULL
level	NULL
of	NULL
expression	NULL
of	NULL
the	NULL
chimeric	NULL
proteins	NULL
was	NULL
decreased	NULL
in	NULL
the	NULL
GALIIP	NULL
strain	NULL
.	NULL

Thus	NULL
the	NULL
GALA4-ZEBRA	NULL
fusions	NULL
were	NULL
placed	NULL
downstream	NULL
of	NULL
the	NULL
GAL4	NULL
promoter	NULL
,	NULL
which	NULL
is	NULL
less	NULL
powerful	NULL
than	NULL
the	NULL
promoter	NULL
,	NULL
in	NULL
plasmids	NULL
with	NULL
low-copy-number	NULL
ARS-CEN	NULL
origins	NULL
of	NULL
replication	NULL
.	NULL

The	NULL
reporter	NULL
,	NULL
containing	NULL
a	NULL
UAS	NULL
,	NULL
,	NULL
bearing	NULL
four	NULL
GAL4	NULL
binding	NULL
sites	NULL
fused	NULL
to	NULL
lacZ	NULL
,	NULL
was	NULL
inserted	NULL
into	NULL
the	NULL
chromosome	NULL
of	NULL
the	NULL
GAL11P	NULL
yeast	NULL
strain	NULL
(	NULL
18	NULL
)	NULL
.	NULL

The	NULL
potency	NULL
of	NULL
GAL4	NULL
(	NULL
1-147	NULL
)	NULL
-Z	NULL
(	NULL
1-245	NULL
)	NULL
increased	NULL
dramatically	NULL
in	NULL
the	NULL
GAL1IP	NULL
yeast	NULL
strain	NULL
.	NULL

When	NULL
isogenic	NULL
yeast	NULL
strains	NULL
with	NULL
and	NULL
without	NULL
the	NULL
potentiator	NULL
mutation	NULL
were	NULL
compared	NULL
,	NULL
the	NULL
intact	NULL
ZEBRA	NULL
protein	NULL
fused	NULL
to	NULL
GALA	NULL
was	NULL
about	NULL
100-fold	NULL
more	NULL
active	NULL
in	NULL
the	NULL
potentiator	NULL
strain	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

Figure	NULL
3B	NULL
shows	NULL
that	NULL
two	NULL
constructs	NULL
which	NULL
contained	NULL
the	NULL
entire	NULL
N-terminal	NULL
activating	NULL
domain	NULL
,	NULL
namely	NULL
,	NULL
GAL4	NULL
(	NULL
1-147	NULL
)	NULL
-Z	NULL
(	NULL
1-198	NULL
)	NULL
and	NULL
GAL4	NULL
(	NULL
1-147	NULL
)	NULL
-Z	NULL
(	NULL
1-93	NULL
)	NULL
,	NULL
both	NULL
behaved	NULL
as	NULL
potent	NULL
activators	NULL
in	NULL
the	NULL
GAL1MIP	NULL
strain	NULL
.	NULL

Of	NULL
various	NULL
subfragments	NULL
of	NULL
the	NULL
N-terminal	NULL
region	NULL
,	NULL
Z	NULL
(	NULL
51-103	NULL
)	NULL
was	NULL
the	NULL
most	NULL
active	NULL
;	NULL
however	NULL
,	NULL
it	NULL
was	NULL
not	NULL
as	NULL
active	NULL
as	NULL
the	NULL
intact	NULL
protein	NULL
or	NULL
fusions	NULL
containing	NULL
the	NULL
entire	NULL
N-terminal	NULL
region	NULL
.	NULL

Activation	NULL
by	NULL
the	NULL
carboxy	NULL
terminus	NULL
of	NULL
ZEBRA	NULL
,	NULL
aa	NULL
228	NULL
to	NULL
245	NULL
,	NULL
increased	NULL
about	NULL
10-fold	NULL
when	NULL
assessed	NULL
in	NULL
the	NULL
potentiator	NULL
strain	NULL
compared	NULL
with	NULL
wild-type	NULL
S.	NULL
cerevisiae	NULL
.	NULL

Although	NULL
the	NULL
N-terminal	NULL
25	NULL
aa	NULL
were	NULL
shown	NULL
to	NULL
be	NULL
important	NULL
in	NULL
progressive	NULL
amino-terminal	NULL
deletion	NULL
analysis	NULL
(	NULL
Fig	NULL
.	NULL

2A	NULL
)	NULL
,	NULL
they	NULL
did	NULL
not	NULL
constitute	NULL
an	NULL
autonomous	NULL
activation	NULL
domain	NULL
when	NULL
fused	NULL
to	NULL
GALA4	NULL
(	NULL
1-147	NULL
)	NULL
and	NULL
tested	NULL
in	NULL
the	NULL
GAL1IP	NULL
strain	NULL
(	NULL
Fig	NULL
.	NULL

3B	NULL
)	NULL
.	NULL

Activation	NULL
by	NULL
ZEBRA	NULL
and	NULL
its	NULL
deletion	NULL
mutants	NULL
in	NULL
human	NULL
B	NULL
cells	NULL
.	NULL

In	NULL
human	NULL
B	NULL
cells	NULL
,	NULL
a	NULL
major	NULL
activation	NULL
domain	NULL
was	NULL
contained	NULL
in	NULL
the	NULL
amino-terminal	NULL
76	NULL
aa	NULL
(	NULL
Fig	NULL
.	NULL

4	NULL
)	NULL
.	NULL

There	NULL
was	NULL
progressive	NULL
loss	NULL
of	NULL
activity	NULL
as	NULL
this	NULL
region	NULL
was	NULL
truncated	NULL
:	NULL
deletion	NULL
of	NULL
the	NULL
N-terminal	NULL
25	NULL
aa	NULL
reduced	NULL
activity	NULL
by	NULL
40	NULL
%	NULL
;	NULL
deletion	NULL
of	NULL
the	NULL
N-terminal	NULL
50	NULL
aa	NULL
reduced	NULL
activity	NULL
by	NULL
more	NULL
than	NULL
90	NULL
%	NULL
.	NULL

Z	NULL
(	NULL
77-245	NULL
)	NULL
,	NULL
Z	NULL
(	NULL
99-245	NULL
)	NULL
,	NULL
and	NULL
Z	NULL
(	NULL
131-245	NULL
)	NULL
were	NULL
inactive	NULL
in	NULL
B	NULL
cells	NULL
.	NULL

All	NULL
of	NULL
the	NULL
N-terminal-deletion	NULL
mutants	NULL
were	NULL
expressed	NULL
in	NULL
mammalian	NULL
cells	NULL
to	NULL
similar	NULL
extents	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

The	NULL
progressive	NULL
decrease	NULL
in	NULL
activity	NULL
associated	NULL
with	NULL
the	NULL
N-terminal	NULL
deletions	NULL
suggested	NULL
that	NULL
aa	NULL
26	NULL
to	NULL
50	NULL
were	NULL
critical	NULL
for	NULL
activation	NULL
in	NULL
B	NULL
cells	NULL
.	NULL

Their	NULL
importance	NULL
was	NULL
also	NULL
evident	NULL
from	NULL
the	NULL
behavior	NULL
of	NULL
internal-deletion	NULL
mutants	NULL
.	NULL

The	NULL
removal	NULL
of	NULL
these	NULL
amino	NULL
acids	NULL
,	NULL
as	NULL
in	NULL
the	NULL
mutants	NULL
Z	NULL
(	NULL
1-25	NULL
,	NULL
89-245	NULL
)	NULL
and	NULL
Z	NULL
(	NULL
1-25	NULL
,	NULL
141-245	NULL
)	NULL
,	NULL
markedly	NULL
reduced	NULL
activity	NULL
;	NULL
the	NULL
larger	NULL
internal	NULL
deletion	NULL
caused	NULL
a	NULL
greater	NULL
loss	NULL
of	NULL
activity	NULL
than	NULL
the	NULL
smaller	NULL
one	NULL
.	NULL

Deletion	NULL
of	NULL
the	NULL
C-terminal	NULL
18	NULL
aa	NULL
reduced	NULL
activity	NULL
in	NULL
B	NULL
cells	NULL
by	NULL
60	NULL
to	NULL
80	NULL
%	NULL
in	NULL
various	NULL
experiments	NULL
.	NULL

In	NULL
related	NULL
experiments	NULL
,	NULL
GAL4	NULL
(	NULL
1-147	NULL
)	NULL
-Z	NULL
(	NULL
1-93	NULL
)	NULL
and	NULL
GAL4	NULL
(	NULL
1-147	NULL
)	NULL
-Z	NULL
(	NULL
228-245	NULL
)	NULL
were	NULL
each	NULL
found	NULL
to	NULL
function	NULL
as	NULL
an	NULL
activator	NULL
in	NULL
human	NULL
B-cell	NULL
lines	NULL
when	NULL
tested	NULL
on	NULL
reporters	NULL
containing	NULL
five	NULL
oligomerized	NULL
GAL4	NULL
binding	NULL
sites	NULL
upstream	NULL
of	NULL
CAT	NULL
(	NULL
data	NULL
not	NULL
FUNCTIONS	NULL
OF	NULL
ZEBRA	NULL
REGIONS	NULL
IN	NULL
YEAST	NULL
AND	NULL
B	NULL
CELLS	NULL
7477	NULL
ZEBRA	NULL
Amino	NULL
Acids	NULL
Stimulation	NULL
index	NULL
%	NULL
WT	NULL
0	NULL
25	NULL
50	NULL
75	NULL
100	NULL
125	NULL
150	NULL
175	NULL
200	NULL
225	NULL
250	NULL
0	NULL
50	NULL
100	NULL
150	NULL
200	NULL
r	NULL
--	NULL
-r	NULL
-r	NULL
--	NULL
a	NULL
-a	NULL
r	NULL
r	NULL
r	NULL
Z	NULL
(	NULL
2-245	NULL
)	NULL
2	NULL
(	NULL
25-245	NULL
)	NULL
2	NULL
(	NULL
51-245	NULL
)	NULL
Z	NULL
(	NULL
77-245	NULL
)	NULL
z	NULL
(	NULL
99-245	NULL
)	NULL
Z	NULL
(	NULL
131-245	NULL
)	NULL
Z	NULL
(	NULL
1-245	NULL
)	NULL
2	NULL
(	NULL
1-25,89-245	NULL
)	NULL
|-Z	NULL
(	NULL
1-25,141-245	NULL
)	NULL
|	NULL
2	NULL
(	NULL
1-227	NULL
)	NULL
Reporter	NULL
:	NULL
23	NULL
E4CAT	NULL
FIG	NULL
.	NULL

4	NULL
.	NULL

Activation	NULL
of	NULL
transcription	NULL
by	NULL
ZEBRA	NULL
and	NULL
ZEBRA	NULL
deletion	NULL
mutants	NULL
in	NULL
human	NULL
B	NULL
cells	NULL
.	NULL

BJAB	NULL
cells	NULL
were	NULL
electroporated	NULL
with	NULL
10	NULL
pg	NULL
of	NULL
an	NULL
activator	NULL
plasmid	NULL
and	NULL
10	NULL
pg	NULL
of	NULL
a	NULL
reporter	NULL
plasmid	NULL
.	NULL

The	NULL
activators	NULL
consisted	NULL
of	NULL
a	NULL
nested	NULL
set	NULL
of	NULL
N-terminal-deletion	NULL
mutants	NULL
of	NULL
ZEBRA	NULL
cloned	NULL
behind	NULL
the	NULL
simian	NULL
virus	NULL
40	NULL
promoter	NULL
in	NULL
the	NULL
vector	NULL
pBXG1	NULL
or	NULL
of	NULL
wild-type	NULL
ZEBRA	NULL
and	NULL
ZEBRA	NULL
internal-deletion	NULL
mutants	NULL
cloned	NULL
behind	NULL
the	NULL
cytomegalovirus	NULL
immediate-early	NULL
promoter	NULL
in	NULL
the	NULL
plasmid	NULL
pHD1013	NULL
.	NULL

The	NULL
double	NULL
horizontal	NULL
line	NULL
indicates	NULL
that	NULL
these	NULL
mutants	NULL
were	NULL
in	NULL
different	NULL
vectors	NULL
and	NULL
contained	NULL
different	NULL
translation	NULL
initiation	NULL
sequences	NULL
.	NULL

The	NULL
reporter	NULL
,	NULL
Z3E4CAT	NULL
,	NULL
contains	NULL
three	NULL
oligomerized	NULL
ZIIIB	NULL
sites	NULL
upstream	NULL
of	NULL
a	NULL
minimal	NULL
adenovirus	NULL
E4	NULL
promoter	NULL
fused	NULL
to	NULL
CAT	NULL
(	NULL
4	NULL
)	NULL
.	NULL

Cell	NULL
extracts	NULL
prepared	NULL
48	NULL
h	NULL
after	NULL
electroporation	NULL
were	NULL
assayed	NULL
for	NULL
CAT	NULL
activity	NULL
.	NULL

Shown	NULL
are	NULL
pooled	NULL
data	NULL
from	NULL
duplicate	NULL
experiments	NULL
.	NULL

The	NULL
stimulation	NULL
of	NULL
transcription	NULL
by	NULL
pBXG1/Z	NULL
(	NULL
2-245	NULL
)	NULL
,	NULL
190-fold	NULL
,	NULL
is	NULL
considered	NULL
100	NULL
%	NULL
in	NULL
the	NULL
N-terminal-deletion	NULL
series	NULL
.	NULL

The	NULL
stimulation	NULL
of	NULL
transcription	NULL
by	NULL
pHD1013/Z	NULL
(	NULL
1-245	NULL
)	NULL
,	NULL
70-fold	NULL
,	NULL
is	NULL
considered	NULL
100	NULL
%	NULL
for	NULL
the	NULL
internal-deletion	NULL
series	NULL
.	NULL

shown	NULL
)	NULL
.	NULL

Thus	NULL
,	NULL
the	NULL
two	NULL
regions	NULL
of	NULL
ZEBRA	NULL
shown	NULL
to	NULL
contain	NULL
important	NULL
activating	NULL
sequences	NULL
by	NULL
deletion	NULL
analysis	NULL
were	NULL
also	NULL
autonomous	NULL
activating	NULL
sequences	NULL
when	NULL
fused	NULL
to	NULL
a	NULL
heterologous	NULL
DNA	NULL
binding	NULL
domain	NULL
.	NULL

Comparing	NULL
behaviors	NULL
of	NULL
deletion	NULL
mutants	NULL
in	NULL
B	NULL
cells	NULL
and	NULL
in	NULL
S.	NULL
cerevisiae	NULL
.	NULL

Figure	NULL
5	NULL
compares	NULL
activities	NULL
of	NULL
the	NULL
mutants	NULL
on	NULL
reporters	NULL
with	NULL
three	NULL
oligomerized	NULL
ZIIIB	NULL
sites	NULL
.	NULL

In	NULL
both	NULL
B	NULL
cells	NULL
and	NULL
S.	NULL
cerevisiae	NULL
,	NULL
the	NULL
extreme	NULL
N	NULL
terminus	NULL
was	NULL
important	NULL
for	NULL
activity	NULL
;	NULL
deletion	NULL
of	NULL
aa	NULL
1	NULL
to	NULL
25	NULL
had	NULL
similar	NULL
effects	NULL
in	NULL
the	NULL
two	NULL
types	NULL
of	NULL
cells	NULL
,	NULL
about	NULL
a	NULL
40-	NULL
to	NULL
50	NULL
%	NULL
loss	NULL
of	NULL
activity	NULL
.	NULL

In	NULL
Fig	NULL
.	NULL

5	NULL
,	NULL
this	NULL
region	NULL
is	NULL
designated	NULL
YI	NULL
and	NULL
BI	NULL
for	NULL
yeast	NULL
cells	NULL
and	NULL
B	NULL
cells	NULL
,	NULL
respectively	NULL
.	NULL

Moreover	NULL
,	NULL
the	NULL
remaining	NULL
N-terminal	NULL
98	NULL
aa	NULL
were	NULL
required	NULL
for	NULL
activity	NULL
in	NULL
both	NULL
yeast	NULL
and	NULL
B	NULL
cells	NULL
,	NULL
since	NULL
the	NULL
mutant	NULL
Z	NULL
(	NULL
99-245	NULL
)	NULL
was	NULL
inactive	NULL
in	NULL
both	NULL
types	NULL
of	NULL
cells	NULL
.	NULL

Progressive	NULL
N-terminal	NULL
and	NULL
internal	NULL
deletions	NULL
implicated	NULL
aa	NULL
26	NULL
to	NULL
50	NULL
,	NULL
a	NULL
region	NULL
designated	NULL
BI	NULL
,	NULL
as	NULL
being	NULL
crucial	NULL
in	NULL
B	NULL
cells	NULL
.	NULL

This	NULL
region	NULL
could	NULL
be	NULL
removed	NULL
without	NULL
altering	NULL
activity	NULL
in	NULL
S.	NULL
cerevisice	NULL
.	NULL

Progressive	NULL
N-terminal	NULL
deletions	NULL
implicated	NULL
aa	NULL
50	NULL
to	NULL
98	NULL
,	NULL
a	NULL
region	NULL
called	NULL
YII	NULL
,	NULL
as	NULL
important	NULL
in	NULL
S.	NULL
cerevisiae	NULL
.	NULL

Furthermore	NULL
,	NULL
as	NULL
shown	NULL
in	NULL
Fig	NULL
.	NULL

3B	NULL
,	NULL
YII	NULL
could	NULL
function	NULL
as	NULL
an	NULL
autonomous	NULL
activating	NULL
region	NULL
in	NULL
S.	NULL
cerevisiae	NULL
when	NULL
fused	NULL
to	NULL
GALA	NULL
.	NULL

This	NULL
region	NULL
also	NULL
served	NULL
a	NULL
function	NULL
in	NULL
B	NULL
cells	NULL
,	NULL
since	NULL
the	NULL
mutant	NULL
Z	NULL
(	NULL
51-245	NULL
)	NULL
was	NULL
still	NULL
active	NULL
while	NULL
Z	NULL
(	NULL
77-245	NULL
)	NULL
was	NULL
inactive	NULL
.	NULL

Deletion	NULL
of	NULL
the	NULL
carboxy-terminal	NULL
18	NULL
aa	NULL
of	NULL
ZEBRA	NULL
,	NULL
a	NULL
region	NULL
called	NULL
BIV	NULL
and	NULL
YIII	NULL
in	NULL
B	NULL
cells	NULL
and	NULL
S.	NULL
cerevisiae	NULL
,	NULL
respectively	NULL
,	NULL
led	NULL
to	NULL
marked	NULL
reduction	NULL
in	NULL
activity	NULL
in	NULL
both	NULL
systems	NULL
.	NULL

DISCUSSION	NULL
Regions	NULL
of	NULL
ZEBRA	NULL
that	NULL
participate	NULL
in	NULL
activation	NULL
in	NULL
S.	NULL
cerevisiae	NULL
.	NULL

Three	NULL
regions	NULL
of	NULL
ZEBRA	NULL
protein	NULL
affect	NULL
the	NULL
capacity	NULL
of	NULL
the	NULL
protein	NULL
to	NULL
activate	NULL
transcription	NULL
in	NULL
S.	NULL
cerevisiae	NULL
.	NULL

None	NULL
of	NULL
the	NULL
regions	NULL
is	NULL
required	NULL
for	NULL
DNA	NULL
binding	NULL
in	NULL
vitro	NULL
(	NULL
36	NULL
,	NULL
47	NULL
)	NULL
.	NULL

Deletion	NULL
of	NULL
region	NULL
YI	NULL
,	NULL
containing	NULL
the	NULL
N-terminal	NULL
25	NULL
aa	NULL
,	NULL
reduced	NULL
the	NULL
capacity	NULL
of	NULL
ZEBRA	NULL
to	NULL
activate	NULL
transcription	NULL
by	NULL
7478	NULL
MILLER	NULL
ET	NULL
AL	NULL
.	NULL

A	NULL
ZEBRA	NULL
Amino	NULL
Acids	NULL
Relative	NULL
Stimulation	NULL
0	NULL
25	NULL
50	NULL
75	NULL
100	NULL
125	NULL
150	NULL
175	NULL
200	NULL
225	NULL
250	NULL
B	NULL
Cells	NULL
Yeast	NULL
2	NULL
(	NULL
2-245	NULL
)	NULL
|	NULL
--	NULL
--	NULL
--	NULL
--	NULL
--	NULL
--	NULL
-	NULL
100	NULL
100	NULL
Z	NULL
(	NULL
25-245	NULL
)	NULL
|	NULL
=	NULL
--	NULL
--	NULL
--	NULL
--	NULL
--	NULL
--	NULL
--	NULL
61	NULL
47	NULL
2	NULL
(	NULL
51-245	NULL
)	NULL
_	NULL
--	NULL
-_	NULL
--	NULL
_	NULL
--	NULL
_-____	NULL
7	NULL
48	NULL
2	NULL
(	NULL
77-245	NULL
)	NULL
azz	NULL
1	NULL
24	NULL
2	NULL
(	NULL
99-245	NULL
)	NULL
_-_	NULL
1	NULL
8	NULL
Z	NULL
(	NULL
131-245	NULL
)	NULL
--	NULL
-	NULL
1	NULL
11	NULL
Z	NULL
(	NULL
1-245	NULL
)	NULL
[	NULL
--	NULL
100	NULL
100	NULL
2	NULL
(	NULL
1-25,89-245	NULL
)	NULL
|	NULL
--	NULL
--	NULL
-	NULL
.	NULL

13	NULL
85	NULL
Z	NULL
(	NULL
1-25,141-245	NULL
)	NULL
|	NULL
--	NULL
3	NULL
78	NULL
Z	NULL
(	NULL
1-227	NULL
)	NULL
--	NULL
--	NULL
--	NULL
--	NULL
--	NULL
--	NULL
--	NULL
20	NULL
17	NULL
Reporter	NULL
:	NULL
23	NULL
E4CAT	NULL
Z3/CZ	NULL
B	NULL
c-	NULL
--	NULL
-	NULL
--	NULL
=	NULL
yeast	NULL
YI	NULL
YII	NULL
YI	NULL
wzzza	NULL
-	NULL
B-cells	NULL
BI	NULL
-	NULL
BHI	NULL
BHI	NULL
BIV	NULL
1	NULL
50	NULL
100	NULL
150	NULL
200	NULL
245	NULL
amino	NULL
acids	NULL
Z	NULL
Required	NULL
in	NULL
$	NULL
2530an	NULL
a.a.	NULL
Domain	NULL
Yeast	NULL
Bcells	NULL
GAL4	NULL
(	NULL
1-147	NULL
)	NULL
Charge	NULL
P	NULL
Q	NULL
1-25	NULL
YI/BI	NULL
+	NULL
+	NULL
-	NULL
-	NULL
(	NULL
3	NULL
)	NULL
4/25	NULL
2/25	NULL
26-50	NULL
BHI	NULL
-	NULL
+	NULL
-	NULL
-	NULL
(	NULL
1	NULL
)	NULL
4/25	NULL
3/25	NULL
51-102	NULL
YNI/BIII	NULL
+	NULL
+	NULL
+	NULL
-	NULL
(	NULL
3	NULL
)	NULL
9/52	NULL
6/52	NULL
228-245	NULL
YIII/BIV	NULL
+	NULL
+	NULL
-	NULL
(	NULL
2	NULL
)	NULL
2/18	NULL
0/18	NULL
+	NULL
FIG	NULL
.	NULL

5	NULL
.	NULL

Comparison	NULL
of	NULL
ZEBRA	NULL
activating	NULL
regions	NULL
which	NULL
function	NULL
in	NULL
S.	NULL
cerevisiae	NULL
and	NULL
in	NULL
B	NULL
cells	NULL
.	NULL

(	NULL
A	NULL
)	NULL
Data	NULL
for	NULL
deletion	NULL
mutants	NULL
.	NULL

A	NULL
series	NULL
of	NULL
deletion	NULL
mutants	NULL
were	NULL
tested	NULL
for	NULL
activity	NULL
in	NULL
S.	NULL
cerevisiae	NULL
(	NULL
Fig	NULL
.	NULL

2	NULL
)	NULL
and	NULL
in	NULL
human	NULL
B	NULL
cells	NULL
(	NULL
Fig	NULL
.	NULL

4	NULL
)	NULL
.	NULL

The	NULL
relative	NULL
stimulation	NULL
is	NULL
derived	NULL
from	NULL
the	NULL
data	NULL
shown	NULL
in	NULL
the	NULL
above-mentioned	NULL
two	NULL
figures	NULL
.	NULL

For	NULL
the	NULL
N-terminal-deletion	NULL
series	NULL
,	NULL
the	NULL
activity	NULL
of	NULL
construct	NULL
Z	NULL
(	NULL
2-245	NULL
)	NULL
is	NULL
considered	NULL
100	NULL
%	NULL
.	NULL

For	NULL
the	NULL
internal	NULL
and	NULL
carboxy-terminal	NULL
deletions	NULL
,	NULL
the	NULL
activity	NULL
of	NULL
an	NULL
intact	NULL
BZLFIL	NULL
cDNA	NULL
is	NULL
considered	NULL
100	NULL
%	NULL
.	NULL

(	NULL
B	NULL
)	NULL
ZEBRA	NULL
activating	NULL
regions	NULL
in	NULL
S.	NULL
cerevisiae	NULL
and	NULL
B	NULL
cells	NULL
.	NULL

In	NULL
the	NULL
column	NULL
headed	NULL
``	NULL
Required	NULL
,	NULL
``	NULL
+	NULL
signifies	NULL
>	NULL
40	NULL
%	NULL
reduction	NULL
upon	NULL
deletion	NULL
.	NULL

Region	NULL
YII	NULL
is	NULL
required	NULL
only	NULL
if	NULL
region	NULL
YI	NULL
or	NULL
YIII	NULL
is	NULL
not	NULL
present	NULL
.	NULL

Under	NULL
the	NULL
column	NULL
headed	NULL
``	NULL
Functions	NULL
,	NULL
``	NULL
+	NULL
signifies	NULL
that	NULL
transcription	NULL
is	NULL
stimulated	NULL
in	NULL
the	NULL
potentiator	NULL
yeast	NULL
strain	NULL
(	NULL
Fig	NULL
.	NULL

3B	NULL
)	NULL
.	NULL

Under	NULL
the	NULL
column	NULL
headed	NULL
``	NULL
Charge	NULL
,	NULL
``	NULL
the	NULL
number	NULL
is	NULL
the	NULL
net	NULL
charge	NULL
of	NULL
the	NULL
region	NULL
.	NULL

Under	NULL
columns	NULL
P	NULL
and	NULL
Q	NULL
are	NULL
the	NULL
number	NULL
of	NULL
prolines	NULL
and	NULL
glutamines	NULL
,	NULL
respectively	NULL
,	NULL
divided	NULL
by	NULL
the	NULL
number	NULL
of	NULL
residues	NULL
in	NULL
the	NULL
region	NULL
.	NULL

more	NULL
than	NULL
40	NULL
%	NULL
;	NULL
however	NULL
,	NULL
this	NULL
region	NULL
did	NULL
not	NULL
serve	NULL
as	NULL
an	NULL
autonomous	NULL
activating	NULL
domain	NULL
when	NULL
fused	NULL
to	NULL
GAL4	NULL
(	NULL
1-147	NULL
)	NULL
.	NULL

Region	NULL
YI	NULL
may	NULL
play	NULL
an	NULL
accessory	NULL
function	NULL
in	NULL
activation	NULL
,	NULL
either	NULL
through	NULL
interaction	NULL
with	NULL
other	NULL
activation	NULL
domains	NULL
of	NULL
ZEBRA	NULL
or	NULL
by	NULL
contacting	NULL
cellular	NULL
proteins	NULL
.	NULL

It	NULL
may	NULL
also	NULL
affect	NULL
protein	NULL
folding	NULL
.	NULL

Region	NULL
YII	NULL
,	NULL
aa	NULL
51	NULL
to	NULL
102	NULL
,	NULL
was	NULL
also	NULL
shown	NULL
to	NULL
be	NULL
important	NULL
in	NULL
S.	NULL
cerevisiae	NULL
through	NULL
analysis	NULL
of	NULL
progressive	NULL
N-terminal	NULL
deletions	NULL
(	NULL
Fig	NULL
.	NULL

2A	NULL
)	NULL
.	NULL

Furthermore	NULL
,	NULL
YII	NULL
functioned	NULL
as	NULL
an	NULL
autonomous	NULL
activation	NULL
domain	NULL
when	NULL
fused	NULL
to	NULL
GAL4	NULL
(	NULL
1-147	NULL
)	NULL
and	NULL
assayed	NULL
in	NULL
the	NULL
GAL	NULL
IP	NULL
strain	NULL
(	NULL
Fig	NULL
.	NULL

3B	NULL
)	NULL
.	NULL

Deletion	NULL
of	NULL
region	NULL
YIII	NULL
,	NULL
residues	NULL
228	NULL
to	NULL
245	NULL
,	NULL
caused	NULL
the	NULL
greatest	NULL
reduction	NULL
in	NULL
activation	NULL
(	NULL
Fig	NULL
.	NULL

2B	NULL
)	NULL
.	NULL

Substitution	NULL
of	NULL
region	NULL
YIII	NULL
with	NULL
VP16	NULL
,	NULL
as	NULL
in	NULL
the	NULL
mutant	NULL
Z	NULL
(	NULL
1-227	NULL
)	NULL
-VP16	NULL
,	NULL
created	NULL
an	NULL
activator	NULL
that	NULL
was	NULL
many	NULL
times	NULL
more	NULL
powerful	NULL
than	NULL
wild-type	NULL
ZEBRA	NULL
.	NULL

Since	NULL
the	NULL
activation	NULL
domain	NULL
of	NULL
VP16	NULL
itself	NULL
does	NULL
not	NULL
bind	NULL
DNA	NULL
,	NULL
this	NULL
finding	NULL
suggests	NULL
that	NULL
removal	NULL
of	NULL
the	NULL
C-terminal	NULL
18	NULL
aa	NULL
from	NULL
ZEBRA	NULL
did	NULL
not	NULL
significantly	NULL
affect	NULL
DNA	NULL
binding	NULL
in	NULL
vivo	NULL
.	NULL

The	NULL
J.	NULL
Viro	NULL
.	NULL

mutant	NULL
Z	NULL
(	NULL
1-227	NULL
)	NULL
binds	NULL
DNA	NULL
in	NULL
vitro	NULL
to	NULL
an	NULL
extent	NULL
comparable	NULL
to	NULL
DNA	NULL
binding	NULL
by	NULL
wild-type	NULL
ZEBRA	NULL
(	NULL
36	NULL
,	NULL
47	NULL
)	NULL
.	NULL

However	NULL
,	NULL
certain	NULL
ZEBRA	NULL
mutants	NULL
with	NULL
deletions	NULL
in	NULL
the	NULL
carboxy-terminal	NULL
18	NULL
aa	NULL
are	NULL
deficient	NULL
in	NULL
binding	NULL
DNA	NULL
in	NULL
vitro	NULL
under	NULL
conditions	NULL
of	NULL
high	NULL
salt	NULL
concentration	NULL
or	NULL
low	NULL
temperature	NULL
(	NULL
36	NULL
,	NULL
47	NULL
)	NULL
.	NULL

Therefore	NULL
we	NULL
can	NULL
not	NULL
exclude	NULL
a	NULL
contribution	NULL
of	NULL
this	NULL
region	NULL
to	NULL
DNA	NULL
binding	NULL
in	NULL
vivo	NULL
.	NULL

Nonetheless	NULL
,	NULL
region	NULL
YIII	NULL
was	NULL
an	NULL
autonomous	NULL
activator	NULL
when	NULL
fused	NULL
to	NULL
GAL4	NULL
(	NULL
1-147	NULL
)	NULL
and	NULL
assayed	NULL
in	NULL
the	NULL
GALIIP	NULL
strain	NULL
(	NULL
Fig	NULL
.	NULL

3B	NULL
)	NULL
.	NULL

One	NULL
model	NULL
to	NULL
account	NULL
for	NULL
the	NULL
results	NULL
of	NULL
deletional	NULL
mutagenesis	NULL
is	NULL
to	NULL
consider	NULL
these	NULL
three	NULL
regions	NULL
of	NULL
ZEBRA	NULL
as	NULL
dependent	NULL
activating	NULL
sequences	NULL
,	NULL
each	NULL
of	NULL
which	NULL
requires	NULL
the	NULL
presence	NULL
of	NULL
another	NULL
activating	NULL
region	NULL
.	NULL

When	NULL
only	NULL
one	NULL
of	NULL
the	NULL
three	NULL
regions	NULL
is	NULL
retained	NULL
,	NULL
the	NULL
mutant	NULL
is	NULL
inactive	NULL
.	NULL

Thus	NULL
,	NULL
mutant	NULL
Z	NULL
(	NULL
99-245	NULL
)	NULL
,	NULL
which	NULL
has	NULL
regions	NULL
YI	NULL
and	NULL
YII	NULL
deleted	NULL
,	NULL
and	NULL
mutant	NULL
Z	NULL
(	NULL
1-25	NULL
,	NULL
141-227	NULL
)	NULL
,	NULL
which	NULL
has	NULL
regions	NULL
YII	NULL
and	NULL
YIII	NULL
deleted	NULL
,	NULL
are	NULL
both	NULL
unable	NULL
to	NULL
activate	NULL
transcription	NULL
(	NULL
Fig	NULL
.	NULL

2	NULL
)	NULL
.	NULL

When	NULL
two	NULL
of	NULL
the	NULL
three	NULL
regions	NULL
are	NULL
present	NULL
,	NULL
the	NULL
mutant	NULL
exhibits	NULL
a	NULL
reduced	NULL
level	NULL
of	NULL
activity	NULL
.	NULL

Thus	NULL
,	NULL
the	NULL
mutant	NULL
with	NULL
only	NULL
region	NULL
YI	NULL
deleted	NULL
,	NULL
Z	NULL
(	NULL
26-245	NULL
)	NULL
,	NULL
would	NULL
be	NULL
considered	NULL
to	NULL
activate	NULL
as	NULL
a	NULL
result	NULL
of	NULL
regions	NULL
YII	NULL
and	NULL
YI	NULL
.	NULL

The	NULL
mutant	NULL
with	NULL
region	NULL
YI	NULL
deleted	NULL
,	NULL
Z	NULL
(	NULL
1-25	NULL
,	NULL
89-245	NULL
)	NULL
,	NULL
activates	NULL
as	NULL
the	NULL
result	NULL
of	NULL
YI	NULL
and	NULL
YIII	NULL
,	NULL
and	NULL
the	NULL
mutant	NULL
with	NULL
region	NULL
YIH	NULL
deleted	NULL
,	NULL
Z	NULL
(	NULL
1-227	NULL
)	NULL
,	NULL
activates	NULL
through	NULL
the	NULL
activity	NULL
of	NULL
YI	NULL
and	NULL
YII	NULL
.	NULL

The	NULL
residual	NULL
activity	NULL
of	NULL
each	NULL
functional	NULL
deletion	NULL
mutant	NULL
can	NULL
be	NULL
accounted	NULL
for	NULL
by	NULL
a	NULL
hierarchy	NULL
of	NULL
importance	NULL
of	NULL
each	NULL
set	NULL
of	NULL
activating	NULL
sequences	NULL
:	NULL
YIII	NULL
>	NULL
YI	NULL
>	NULL
YII	NULL
.	NULL

The	NULL
least	NULL
active	NULL
deletion	NULL
mutant	NULL
contains	NULL
YI	NULL
and	NULL
YII	NULL
.	NULL

The	NULL
most	NULL
active	NULL
deletion	NULL
mutant	NULL
contains	NULL
YIII	NULL
and	NULL
YI	NULL
(	NULL
Fig	NULL
.	NULL

2B	NULL
and	NULL
5B	NULL
)	NULL
.	NULL

The	NULL
GAL4-ZEBRA	NULL
fusions	NULL
were	NULL
consistent	NULL
with	NULL
the	NULL
idea	NULL
that	NULL
two	NULL
groups	NULL
of	NULL
activating	NULL
sequences	NULL
were	NULL
required	NULL
for	NULL
ZEBRA	NULL
to	NULL
activate	NULL
transcription	NULL
in	NULL
S.	NULL
cerevisiae	NULL
.	NULL

A	NULL
chimeric	NULL
mutant	NULL
containing	NULL
regions	NULL
YI	NULL
and	NULL
YII	NULL
,	NULL
GAL4	NULL
(	NULL
1-147	NULL
)	NULL
-Z	NULL
(	NULL
1-93	NULL
)	NULL
,	NULL
functioned	NULL
as	NULL
an	NULL
activator	NULL
in	NULL
wild-type	NULL
yeast	NULL
strains	NULL
.	NULL

However	NULL
,	NULL
neither	NULL
region	NULL
YI	NULL
nor	NULL
YI	NULL
alone	NULL
functioned	NULL
as	NULL
an	NULL
activating	NULL
sequence	NULL
when	NULL
fused	NULL
to	NULL
GAL4	NULL
and	NULL
assayed	NULL
in	NULL
wild-type	NULL
S.	NULL
cerevisiae	NULL
.	NULL

Nonetheless	NULL
,	NULL
region	NULL
YII	NULL
was	NULL
functional	NULL
when	NULL
fused	NULL
to	NULL
GAL4	NULL
(	NULL
1-147	NULL
)	NULL
and	NULL
expressed	NULL
in	NULL
GALIIP	NULL
yeast	NULL
cells	NULL
(	NULL
Fig	NULL
.	NULL

3B	NULL
)	NULL
.	NULL

In	NULL
this	NULL
yeast	NULL
strain	NULL
,	NULL
GAL4	NULL
(	NULL
1-147	NULL
)	NULL
by	NULL
itself	NULL
behaves	NULL
as	NULL
a	NULL
weak	NULL
activator	NULL
(	NULL
18	NULL
)	NULL
.	NULL

It	NULL
is	NULL
possible	NULL
that	NULL
the	NULL
activity	NULL
of	NULL
ZEBRA	NULL
YII	NULL
was	NULL
revealed	NULL
in	NULL
the	NULL
GAL1IP	NULL
strain	NULL
through	NULL
synergy	NULL
with	NULL
the	NULL
cryptic	NULL
activating	NULL
sequences	NULL
in	NULL
GALA	NULL
(	NULL
1-147	NULL
)	NULL
.	NULL

Whatever	NULL
the	NULL
mechanism	NULL
of	NULL
action	NULL
of	NULL
the	NULL
GAL1IP	NULL
mutation	NULL
,	NULL
it	NULL
serves	NULL
as	NULL
a	NULL
useful	NULL
tool	NULL
for	NULL
the	NULL
detection	NULL
of	NULL
weak	NULL
activation	NULL
domains	NULL
by	NULL
increasing	NULL
their	NULL
capacity	NULL
to	NULL
activate	NULL
transcription	NULL
.	NULL

A	NULL
paradoxical	NULL
result	NULL
was	NULL
that	NULL
the	NULL
chimeric	NULL
protein	NULL
GALA	NULL
(	NULL
1-147	NULL
)	NULL
-Z	NULL
(	NULL
1-227	NULL
)	NULL
,	NULL
which	NULL
contains	NULL
ZEBRA	NULL
regions	NULL
YI	NULL
and	NULL
YII	NULL
,	NULL
did	NULL
not	NULL
activate	NULL
either	NULL
in	NULL
wild-type	NULL
or	NULL
potentiator	NULL
yeast	NULL
strains	NULL
.	NULL

While	NULL
this	NULL
result	NULL
may	NULL
be	NULL
explained	NULL
by	NULL
a	NULL
problem	NULL
in	NULL
protein	NULL
folding	NULL
,	NULL
another	NULL
interpretation	NULL
is	NULL
that	NULL
an	NULL
internal	NULL
portion	NULL
of	NULL
the	NULL
ZEBRA	NULL
protein	NULL
may	NULL
exert	NULL
an	NULL
inhibitory	NULL
effect	NULL
on	NULL
transcriptional	NULL
activation	NULL
.	NULL

Inhibitory	NULL
sequences	NULL
in	NULL
the	NULL
central	NULL
region	NULL
of	NULL
the	NULL
GAL4	NULL
protein	NULL
have	NULL
recently	NULL
been	NULL
characterized	NULL
(	NULL
44	NULL
,	NULL
46	NULL
)	NULL
.	NULL

GALA	NULL
,	NULL
like	NULL
ZEBRA	NULL
,	NULL
has	NULL
activation	NULL
domains	NULL
at	NULL
the	NULL
amino	NULL
and	NULL
carboxy	NULL
termini	NULL
,	NULL
separated	NULL
by	NULL
a	NULL
large	NULL
internal	NULL
domain	NULL
which	NULL
contains	NULL
the	NULL
inhibitory	NULL
region	NULL
.	NULL

What	NULL
is	NULL
the	NULL
nature	NULL
of	NULL
these	NULL
dependent	NULL
activation	NULL
domains	NULL
?	NULL

They	NULL
are	NULL
all	NULL
weakly	NULL
acidic	NULL
;	NULL
perhaps	NULL
the	NULL
accumulation	NULL
of	NULL
net	NULL
negative	NULL
charge	NULL
turns	NULL
the	NULL
whole	NULL
protein	NULL
into	NULL
an	NULL
activator	NULL
(	NULL
12	NULL
,	NULL
37	NULL
)	NULL
.	NULL

However	NULL
,	NULL
the	NULL
hypothesis	NULL
that	NULL
negative	NULL
charge	NULL
by	NULL
itself	NULL
is	NULL
a	NULL
major	NULL
determinant	NULL
of	NULL
activation	NULL
potency	NULL
seems	NULL
unlikely	NULL
,	NULL
since	NULL
deletion	NULL
of	NULL
YIII	NULL
,	NULL
with	NULL
a	NULL
charge	NULL
of	NULL
-2	NULL
,	NULL
has	NULL
a	NULL
major	NULL
effect	NULL
on	NULL
activation	NULL
potency	NULL
but	NULL
deletion	NULL
of	NULL
YII	NULL
,	NULL
with	NULL
a	NULL
charge	NULL
of	NULL
-3	NULL
,	NULL
has	NULL
little	NULL
or	NULL
no	NULL
effect	NULL
(	NULL
Fig	NULL
.	NULL

5B	NULL
)	NULL
.	NULL

Regions	NULL
YI	NULL
and	NULL
YII	NULL
are	NULL
both	NULL
relatively	NULL
proline	NULL
rich	NULL
(	NULL
16	NULL
%	NULL
)	NULL
.	NULL

YII	NULL
is	NULL
moderately	NULL
glutamine	NULL
rich	NULL
(	NULL
11	NULL
%	NULL
)	NULL
(	NULL
Fig	NULL
.	NULL

5B	NULL
)	NULL
.	NULL

Region	NULL
YIII	NULL
contains	NULL
a	NULL
consensus	NULL
site	NULL
for	NULL
cdc2	NULL
kinase	NULL
,	NULL
suggesting	NULL
,	NULL
perhaps	NULL
,	NULL
that	NULL
phosphorylation	NULL
,	NULL
and	NULL
the	NULL
Vor	NULL
.	NULL

67	NULL
,	NULL
1993	NULL
resulting	NULL
increase	NULL
in	NULL
net	NULL
negative	NULL
charge	NULL
,	NULL
may	NULL
contribute	NULL
to	NULL
ZEBRA	NULL
's	NULL
capacity	NULL
to	NULL
behave	NULL
as	NULL
an	NULL
activator	NULL
.	NULL

Point	NULL
mutagenesis	NULL
is	NULL
needed	NULL
to	NULL
define	NULL
the	NULL
requirements	NULL
for	NULL
these	NULL
different	NULL
motifs	NULL
in	NULL
transcriptional	NULL
activation	NULL
(	NULL
20	NULL
)	NULL
.	NULL

Parallels	NULL
in	NULL
activating	NULL
behavior	NULL
of	NULL
ZEBRA	NULL
in	NULL
S.	NULL
cerevisiae	NULL
and	NULL
in	NULL
human	NULL
B	NULL
cells	NULL
.	NULL

In	NULL
S.	NULL
cerevisice	NULL
and	NULL
in	NULL
human	NULL
B	NULL
cells	NULL
,	NULL
ZEBRA	NULL
behaves	NULL
as	NULL
a	NULL
sequence-specific	NULL
activator	NULL
of	NULL
transcrip-tion	NULL
;	NULL
it	NULL
activates	NULL
transcription	NULL
of	NULL
reporter	NULL
genes	NULL
bearing	NULL
ZREs	NULL
,	NULL
and	NULL
it	NULL
does	NULL
not	NULL
activate	NULL
reporter	NULL
genes	NULL
lacking	NULL
such	NULL
elements	NULL
or	NULL
those	NULL
containing	NULL
binding	NULL
sites	NULL
for	NULL
another	NULL
EBV	NULL
regulatory	NULL
protein	NULL
,	NULL
such	NULL
as	NULL
EBNA-1	NULL
.	NULL

The	NULL
genes	NULL
responsive	NULL
to	NULL
ZEBRA	NULL
's	NULL
action	NULL
in	NULL
S.	NULL
cerevisiae	NULL
may	NULL
bear	NULL
synthetic	NULL
promoters	NULL
with	NULL
oligomerized	NULL
ZREs	NULL
,	NULL
or	NULL
they	NULL
may	NULL
contain	NULL
natural	NULL
promoters	NULL
of	NULL
viral	NULL
genes	NULL
,	NULL
such	NULL
as	NULL
BMRF-1	NULL
and	NULL
BZLF1	NULL
,	NULL
which	NULL
are	NULL
activated	NULL
by	NULL
ZEBRA	NULL
as	NULL
it	NULL
switches	NULL
latent	NULL
EBV	NULL
to	NULL
lytic	NULL
replication	NULL
in	NULL
human	NULL
B	NULL
cells	NULL
(	NULL
6a	NULL
)	NULL
.	NULL

ZEBRA	NULL
's	NULL
action	NULL
is	NULL
through	NULL
direct	NULL
contact	NULL
with	NULL
DNA	NULL
,	NULL
both	NULL
in	NULL
S.	NULL
cerevisiae	NULL
and	NULL
in	NULL
human	NULL
B	NULL
cells	NULL
.	NULL

ZEBRA	NULL
mutants	NULL
,	NULL
such	NULL
as	NULL
Z	NULL
(	NULL
M178-180	NULL
)	NULL
,	NULL
which	NULL
do	NULL
not	NULL
bind	NULL
DNA	NULL
fail	NULL
to	NULL
activate	NULL
synthetic	NULL
promoters	NULL
(	NULL
Fig	NULL
.	NULL

2B	NULL
)	NULL
and	NULL
certain	NULL
natural	NULL
promoters	NULL
,	NULL
such	NULL
as	NULL
BMRF-1	NULL
,	NULL
in	NULL
S.	NULL
cerevisiae	NULL
and	NULL
in	NULL
B	NULL
cells	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

In	NULL
fact	NULL
,	NULL
transcriptional	NULL
activation	NULL
of	NULL
oligomerized	NULL
ZIIIB	NULL
sites	NULL
in	NULL
S.	NULL
cerevisiae	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
the	NULL
DNA	NULL
binding	NULL
mutants	NULL
is	NULL
lower	NULL
than	NULL
background	NULL
level	NULL
(	NULL
Fig	NULL
.	NULL

2B	NULL
)	NULL
.	NULL

These	NULL
mutants	NULL
might	NULL
lead	NULL
to	NULL
less-than-background-level	NULL
activation	NULL
through	NULL
formation	NULL
of	NULL
heterodimers	NULL
with	NULL
endogenous	NULL
yeast	NULL
proteins	NULL
which	NULL
bind	NULL
ZIIIB	NULL
sites	NULL
.	NULL

This	NULL
might	NULL
prevent	NULL
the	NULL
yeast	NULL
proteins	NULL
from	NULL
binding	NULL
DNA	NULL
or	NULL
activating	NULL
transcription	NULL
,	NULL
or	NULL
both	NULL
.	NULL

ZEBRA	NULL
is	NULL
a	NULL
weak	NULL
activator	NULL
in	NULL
S.	NULL
cerevisiae	NULL
,	NULL
as	NULL
it	NULL
is	NULL
in	NULL
human	NULL
B	NULL
cells	NULL
.	NULL

In	NULL
S.	NULL
cerevisiae	NULL
,	NULL
the	NULL
activation	NULL
potency	NULL
of	NULL
ZEBRA	NULL
is	NULL
about	NULL
one-fifth	NULL
that	NULL
of	NULL
GAL4	NULL
region	NULL
II	NULL
,	NULL
the	NULL
strong	NULL
carboxy-terminal	NULL
activating	NULL
domain	NULL
of	NULL
GAL4	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

Fusion	NULL
of	NULL
the	NULL
powerful	NULL
activation	NULL
domain	NULL
of	NULL
herpes	NULL
simplex	NULL
virus	NULL
VP16	NULL
to	NULL
ZEBRA	NULL
increases	NULL
its	NULL
activation	NULL
potency	NULL
6-	NULL
to	NULL
20-fold	NULL
in	NULL
human	NULL
B	NULL
cells	NULL
and	NULL
about	NULL
S5-fold	NULL
in	NULL
S.	NULL
cerevisiae	NULL
(	NULL
1	NULL
)	NULL
.	NULL

As	NULL
is	NULL
particularly	NULL
characteristic	NULL
of	NULL
weak	NULL
activators	NULL
,	NULL
transcriptional	NULL
activity	NULL
by	NULL
ZEBRA	NULL
is	NULL
synergistic	NULL
.	NULL

Model	NULL
promoters	NULL
with	NULL
a	NULL
single	NULL
binding	NULL
site	NULL
are	NULL
activated	NULL
poorly	NULL
in	NULL
human	NULL
B	NULL
cells	NULL
and	NULL
in	NULL
S.	NULL
cerevisiae	NULL
.	NULL

Promoters	NULL
with	NULL
two	NULL
or	NULL
more	NULL
binding	NULL
sites	NULL
are	NULL
activated	NULL
strongly	NULL
in	NULL
both	NULL
systems	NULL
.	NULL

The	NULL
same	NULL
magnitude	NULL
of	NULL
synergy	NULL
is	NULL
observed	NULL
in	NULL
vivo	NULL
in	NULL
human	NULL
B	NULL
cells	NULL
,	NULL
in	NULL
vitro	NULL
in	NULL
a	NULL
HeLa	NULL
cell	NULL
extract	NULL
,	NULL
and	NULL
in	NULL
S.	NULL
cerevisiqe	NULL
(	NULL
4	NULL
)	NULL
.	NULL

Conservation	NULL
of	NULL
ZEBRA	NULL
's	NULL
activating	NULL
regions	NULL
in	NULL
S.	NULL
cerevisiae	NULL
and	NULL
in	NULL
human	NULL
B	NULL
cells	NULL
.	NULL

The	NULL
overall	NULL
functional	NULL
architecture	NULL
of	NULL
ZEBRA	NULL
protein	NULL
is	NULL
preserved	NULL
in	NULL
S.	NULL
cerevisice	NULL
and	NULL
in	NULL
human	NULL
B	NULL
cells	NULL
.	NULL

A	NULL
complex	NULL
activation	NULL
domain	NULL
consisting	NULL
of	NULL
several	NULL
subregions	NULL
is	NULL
contained	NULL
in	NULL
the	NULL
N-terminal	NULL
98	NULL
aa	NULL
;	NULL
deletion	NULL
of	NULL
this	NULL
entire	NULL
region	NULL
severely	NULL
impairs	NULL
activation	NULL
both	NULL
in	NULL
S.	NULL
cerevisiae	NULL
and	NULL
in	NULL
mammalian	NULL
cells	NULL
(	NULL
Fig	NULL
.	NULL

2A	NULL
and	NULL
4	NULL
)	NULL
(	NULL
11	NULL
,	NULL
15	NULL
,	NULL
36	NULL
)	NULL
.	NULL

This	NULL
region	NULL
represents	NULL
an	NULL
autonomous	NULL
domain	NULL
sufficient	NULL
to	NULL
activate	NULL
transcription	NULL
when	NULL
fused	NULL
to	NULL
GAL4	NULL
and	NULL
expressed	NULL
in	NULL
S.	NULL
cerevisiae	NULL
ot	NULL
in	NULL
mammalian	NULL
cells	NULL
(	NULL
Fig	NULL
.	NULL

3	NULL
)	NULL
(	NULL
reference	NULL
11	NULL
and	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

Furthermore	NULL
,	NULL
we	NULL
show	NULL
here	NULL
for	NULL
the	NULL
first	NULL
time	NULL
that	NULL
the	NULL
carboxy-terminal	NULL
18	NULL
aa	NULL
contribute	NULL
to	NULL
ZEBRA	NULL
's	NULL
ability	NULL
to	NULL
behave	NULL
as	NULL
an	NULL
activator	NULL
in	NULL
EBV-negative	NULL
B	NULL
cells	NULL
and	NULL
in	NULL
S.	NULL
cerevisiae	NULL
and	NULL
also	NULL
constitute	NULL
an	NULL
autonomous	NULL
activating	NULL
region	NULL
.	NULL

Experiments	NULL
that	NULL
examine	NULL
the	NULL
capacity	NULL
of	NULL
activators	NULL
to	NULL
work	NULL
in	NULL
heterologous	NULL
systems	NULL
have	NULL
led	NULL
to	NULL
the	NULL
hypothesis	NULL
that	NULL
some	NULL
activators	NULL
are	NULL
``	NULL
universal	NULL
``	NULL
and	NULL
others	NULL
are	NULL
``	NULL
specialized	NULL
``	NULL
(	NULL
38	NULL
)	NULL
.	NULL

Universal	NULL
activators	NULL
,	NULL
such	NULL
as	NULL
the	NULL
acidic	NULL
C-terminal	NULL
80	NULL
aa	NULL
of	NULL
the	NULL
powerful	NULL
herpes	NULL
simplex	NULL
virus	NULL
activator	NULL
VP16	NULL
or	NULL
the	NULL
C-terminal	NULL
114	NULL
aa	NULL
of	NULL
the	NULL
S.	NULL
cerevisiae	NULL
activator	NULL
GALA	NULL
,	NULL
operate	NULL
in	NULL
a	NULL
wide	NULL
variety	NULL
of	NULL
eukaryotic	NULL
cells	NULL
,	NULL
including	NULL
those	NULL
of	NULL
yeasts	NULL
,	NULL
insects	NULL
,	NULL
and	NULL
mammals	NULL
(	NULL
2	NULL
,	NULL
6	NULL
,	NULL
23	NULL
,	NULL
40	NULL
)	NULL
.	NULL

Furthermore	NULL
,	NULL
some	NULL
point	NULL
mutations	NULL
of	NULL
GALA	NULL
increase	NULL
or	NULL
decrease	NULL
its	NULL
activation	NULL
potency	NULL
in	NULL
the	NULL
same	NULL
direction	NULL
in	NULL
both	NULL
yeast	NULL
and	NULL
mammalian	NULL
cells	NULL
(	NULL
12	NULL
)	NULL
.	NULL

FUNCTIONS	NULL
OF	NULL
ZEBRA	NULL
REGIONS	NULL
IN	NULL
YEAST	NULL
AND	NULL
B	NULL
CELLS	NULL
7479	NULL
Specialized	NULL
activators	NULL
,	NULL
such	NULL
as	NULL
the	NULL
glutamine-rich	NULL
domain	NULL
of	NULL
the	NULL
Sp-1	NULL
transcription	NULL
factor	NULL
,	NULL
work	NULL
in	NULL
mammalian	NULL
cells	NULL
but	NULL
not	NULL
in	NULL
yeast	NULL
cells	NULL
(	NULL
13	NULL
)	NULL
.	NULL

Universal	NULL
activators	NULL
are	NULL
thought	NULL
to	NULL
contact	NULL
some	NULL
component	NULL
of	NULL
the	NULL
transcription	NULL
machinery	NULL
which	NULL
is	NULL
highly	NULL
conserved	NULL
through	NULL
evolution	NULL
(	NULL
13	NULL
,	NULL
17	NULL
)	NULL
.	NULL

In	NULL
the	NULL
sense	NULL
that	NULL
a	NULL
universal	NULL
activator	NULL
can	NULL
function	NULL
in	NULL
both	NULL
yeast	NULL
and	NULL
mammalian	NULL
cells	NULL
,	NULL
ZEBRA	NULL
fits	NULL
the	NULL
definition	NULL
.	NULL

However	NULL
,	NULL
certain	NULL
mutants	NULL
with	NULL
deletions	NULL
in	NULL
ZEBRA\	NULL
's	NULL
N-terminal	NULL
activating	NULL
region	NULL
behaved	NULL
in	NULL
a	NULL
discordant	NULL
fashion	NULL
in	NULL
S.	NULL
cerevisiae	NULL
and	NULL
in	NULL
human	NULL
B	NULL
cells	NULL
.	NULL

For	NULL
example	NULL
,	NULL
removal	NULL
of	NULL
the	NULL
N-terminal	NULL
50	NULL
aa	NULL
reduced	NULL
ZEBRA	NULL
's	NULL
activity	NULL
to	NULL
7	NULL
%	NULL
of	NULL
the	NULL
wild-type	NULL
level	NULL
in	NULL
B	NULL
cells	NULL
but	NULL
only	NULL
to	NULL
48	NULL
%	NULL
of	NULL
the	NULL
wild-type	NULL
level	NULL
in	NULL
S.	NULL
cerevisiae	NULL
.	NULL

Moreover	NULL
,	NULL
in	NULL
the	NULL
progressive	NULL
N-terminal-deletion	NULL
series	NULL
,	NULL
removal	NULL
of	NULL
ZEBRA	NULL
aa	NULL
26	NULL
to	NULL
50	NULL
caused	NULL
a	NULL
major	NULL
reduction	NULL
of	NULL
activity	NULL
in	NULL
B	NULL
cells	NULL
but	NULL
had	NULL
no	NULL
effect	NULL
in	NULL
8.	NULL
cerevisiae	NULL
.	NULL

Furthermore	NULL
,	NULL
the	NULL
internal	NULL
deletion	NULL
of	NULL
aa	NULL
26	NULL
to	NULL
88	NULL
caused	NULL
only	NULL
minimal	NULL
loss	NULL
of	NULL
activity	NULL
in	NULL
S.	NULL
cerevisiae	NULL
and	NULL
profound	NULL
diminution	NULL
in	NULL
B	NULL
cells	NULL
.	NULL

These	NULL
results	NULL
indicate	NULL
that	NULL
a	NULL
region	NULL
containing	NULL
aa	NULL
26	NULL
to	NULL
50	NULL
is	NULL
an	NULL
essential	NULL
component	NULL
of	NULL
ZEBRA	NULL
's	NULL
activating	NULL
domain	NULL
in	NULL
human	NULL
B	NULL
cells	NULL
but	NULL
not	NULL
in	NULL
S.	NULL
cerevisiae	NULL
.	NULL

Others	NULL
have	NULL
also	NULL
implicated	NULL
this	NULL
region	NULL
as	NULL
important	NULL
for	NULL
activation	NULL
by	NULL
ZEBRA	NULL
in	NULL
other	NULL
mammalian	NULL
cells	NULL
such	NULL
as	NULL
HeLa	NULL
and	NULL
EBV-negative	NULL
Burkitt	NULL
lymphoma	NULL
cells	NULL
(	NULL
11	NULL
,	NULL
15	NULL
)	NULL
.	NULL

In	NULL
related	NULL
work	NULL
,	NULL
two	NULL
of	NULL
us	NULL
(	NULL
T.C	NULL
.	NULL

and	NULL
M.C	NULL
.	NULL
)	NULL

have	NULL
found	NULL
that	NULL
aa	NULL
26	NULL
to	NULL
51	NULL
function	NULL
as	NULL
an	NULL
autonomous	NULL
activating	NULL
domain	NULL
when	NULL
fused	NULL
to	NULL
GAL4	NULL
(	NULL
1-147	NULL
)	NULL
and	NULL
assayed	NULL
in	NULL
mammalian	NULL
epithelial	NULL
(	NULL
Cos-1	NULL
)	NULL
cells	NULL
.	NULL

The	NULL
question	NULL
is	NULL
whether	NULL
those	NULL
mutations	NULL
which	NULL
have	NULL
a	NULL
greater	NULL
effect	NULL
on	NULL
the	NULL
activity	NULL
of	NULL
ZEBRA	NULL
in	NULL
mammalian	NULL
cells	NULL
than	NULL
in	NULL
yeast	NULL
disqualify	NULL
the	NULL
protein	NULL
as	NULL
a	NULL
universal	NULL
activator	NULL
.	NULL

One	NULL
possible	NULL
cellular	NULL
target	NULL
for	NULL
ZEBRA	NULL
's	NULL
action	NULL
is	NULL
the	NULL
TATA-binding	NULL
protein	NULL
,	NULL
TBP	NULL
(	NULL
35	NULL
)	NULL
.	NULL

The	NULL
carboxy-terminal	NULL
180	NULL
aa	NULL
of	NULL
this	NULL
protein	NULL
are	NULL
highly	NULL
conserved	NULL
through	NULL
evolution	NULL
(	NULL
3	NULL
,	NULL
13	NULL
,	NULL
17	NULL
,	NULL
19	NULL
,	NULL
35	NULL
)	NULL
.	NULL

It	NULL
has	NULL
been	NULL
shown	NULL
that	NULL
ZEBRA	NULL
can	NULL
interact	NULL
directly	NULL
with	NULL
TBP	NULL
and	NULL
that	NULL
amino	NULL
acids	NULL
in	NULL
ZEBRA	NULL
's	NULL
N-terminal	NULL
region	NULL
are	NULL
required	NULL
for	NULL
this	NULL
interaction	NULL
(	NULL
27	NULL
)	NULL
.	NULL

A	NULL
likely	NULL
hypothesis	NULL
is	NULL
that	NULL
some	NULL
of	NULL
these	NULL
amino	NULL
acids	NULL
also	NULL
interact	NULL
with	NULL
yeast	NULL
TBP	NULL
and	NULL
account	NULL
for	NULL
ZEBRA	NULL
's	NULL
universal	NULL
behavior	NULL
.	NULL

Those	NULL
amino	NULL
acids	NULL
of	NULL
ZEBRA	NULL
which	NULL
are	NULL
required	NULL
in	NULL
mammalian	NULL
cells	NULL
but	NULL
not	NULL
in	NULL
S.	NULL
cerevisiae	NULL
may	NULL
reflect	NULL
interactions	NULL
between	NULL
ZEBRA	NULL
and	NULL
nonconserved	NULL
regions	NULL
in	NULL
the	NULL
amino	NULL
terminus	NULL
of	NULL
TBP	NULL
which	NULL
are	NULL
specific	NULL
for	NULL
mammalian	NULL
cells	NULL
or	NULL
interactions	NULL
between	NULL
ZEBRA	NULL
and	NULL
other	NULL
proteins	NULL
,	NULL
such	NULL
as	NULL
TBP	NULL
-associated	NULL
factors	NULL
,	NULL
which	NULL
are	NULL
not	NULL
thought	NULL
to	NULL
be	NULL
conserved	NULL
in	NULL
evolution	NULL
(	NULL
39	NULL
)	NULL
.	NULL

Thus	NULL
,	NULL
ZEBRA	NULL
has	NULL
attributes	NULL
of	NULL
both	NULL
a	NULL
universal	NULL
and	NULL
a	NULL
specialized	NULL
activator	NULL
.	NULL

ACKNOWLEDGMENTS	NULL
We	NULL
are	NULL
grateful	NULL
to	NULL
Mark	NULL
Ptashne	NULL
for	NULL
advice	NULL
and	NULL
encouragement	NULL
.	NULL

We	NULL
thank	NULL
Peter	NULL
Broad	NULL
,	NULL
Paul	NULL
Farrell	NULL
,	NULL
Erik	NULL
Flemington	NULL
,	NULL
Grace	NULL
Gill	NULL
,	NULL
Clark	NULL
Huang	NULL
,	NULL
Jun	NULL
Ma	NULL
,	NULL
Anita	NULL
Mikeljohn	NULL
,	NULL
Susan	NULL
Oleski	NULL
,	NULL
Maryellen	NULL
Polvino-Bodnar	NULL
,	NULL
Ivan	NULL
Sadowski	NULL
,	NULL
Sam	NULL
Speck	NULL
,	NULL
and	NULL
James	NULL
Wang	NULL
for	NULL
gifts	NULL
of	NULL
plasmids	NULL
.	NULL

We	NULL
give	NULL
special	NULL
thanks	NULL
to	NULL
Joe	NULL
Pearlberg	NULL
for	NULL
yeast	NULL
strains	NULL
.	NULL

This	NULL
work	NULL
was	NULL
supported	NULL
by	NULL
grants	NULL
from	NULL
the	NULL
American	NULL
Cancer	NULL
Society	NULL
(	NULL
MV-547	NULL
and	NULL
VM-24M	NULL
)	NULL
to	NULL
MC	NULL
.	NULL

and	NULL
G.M	NULL
.	NULL

and	NULL
from	NULL
the	NULL
NIH	NULL
(	NULL
CA12055	NULL
and	NULL
GM32308	NULL
)	NULL
to	NULL
G.M	NULL
.	NULL

and	NULL
M.P	NULL
.	NULL

The	NULL
work	NULL
was	NULL
initiated	NULL
when	NULL
George	NULL
Miller	NULL
was	NULL
an	NULL
American	NULL
Cancer	NULL
Society	NULL
faculty	NULL
scholar	NULL
in	NULL
the	NULL
laboratory	NULL
of	NULL
Mark	NULL
Ptashne	NULL
.	NULL

REFERENCES	NULL
1	NULL
.	NULL

Baumann	NULL
,	NULL
R.	NULL
,	NULL
E.	NULL
Grogan	NULL
,	NULL
M.	NULL
Ptashne	NULL
,	NULL
and	NULL
G.	NULL
Miller	NULL
,	NULL
1993	NULL
.	NULL

Changing	NULL
Epstein-Barr	NULL
viral	NULL
ZEBRA	NULL
protein	NULL
into	NULL
a	NULL
more	NULL
powerful	NULL
activator	NULL
enhances	NULL
its	NULL
capacity	NULL
to	NULL
disrupt	NULL
latency	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
90:4436-4440	NULL
.	NULL

2	NULL
.	NULL

Berger	NULL
,	NULL
S.	NULL
L.	NULL
,	NULL
B.	NULL
Pina	NULL
,	NULL
N.	NULL
Silverman	NULL
,	NULL
G.	NULL
Marcus	NULL
,	NULL
J.	NULL
Agapite	NULL
,	NULL
J.	NULL
Regier	NULL
,	NULL
S.	NULL
Triezenberg	NULL
,	NULL
and	NULL
L.	NULL
Guarente	NULL
.	NULL

1992	NULL
.	NULL

Genetic	NULL
isolation	NULL
748	NULL
(	NULL
ba	NULL
.	NULL

9	NULL
.	NULL

10	NULL
.	NULL

16	NULL
.	NULL

19	NULL
.	NULL

20.	NULL
.	NULL

Greenblatt	NULL
,	NULL
J	NULL
.	NULL
)	NULL

MILLER	NULL
ET	NULL
AL	NULL
.	NULL

of	NULL
ADA2	NULL
:	NULL
a	NULL
potential	NULL
transcriptional	NULL
adapter	NULL
required	NULL
for	NULL
function	NULL
of	NULL
certain	NULL
acidic	NULL
activation	NULL
domains	NULL
.	NULL

Cell	NULL
70:25	NULL
1-265.	NULL
.	NULL

Buratowski	NULL
,	NULL
S.	NULL
,	NULL
S.	NULL
Hahn	NULL
,	NULL
P.	NULL
Sharp	NULL
,	NULL
and	NULL
L.	NULL
Guarente	NULL
.	NULL

1988	NULL
.	NULL

Function	NULL
of	NULL
a	NULL
yeast	NULL
TATA	NULL
element-binding	NULL
protein	NULL
in	NULL
a	NULL
mammalian	NULL
transcription	NULL
system	NULL
.	NULL

Nature	NULL
(	NULL
London	NULL
)	NULL
334:37-42.	NULL
.	NULL

Carey	NULL
,	NULL
M.	NULL
,	NULL
J.	NULL
Kolman	NULL
,	NULL
D.	NULL
A.	NULL
Katz	NULL
,	NULL
L.	NULL
Gradoville	NULL
,	NULL
L.	NULL
Barberis	NULL
,	NULL
and	NULL
G.	NULL
Miller	NULL
.	NULL

1992	NULL
.	NULL

Transcriptional	NULL
synergy	NULL
by	NULL
the	NULL
Epstein-Barr	NULL
virus	NULL
transactivator	NULL
ZEBRA	NULL
.	NULL

J.	NULL
Virol	NULL
.	NULL

66:4803-4813.	NULL
.	NULL

Chang	NULL
,	NULL
Y.-N.	NULL
,	NULL
D.	NULL
L.-Y	NULL
.	NULL

Dong	NULL
,	NULL
G.	NULL
S.	NULL
Hayward	NULL
,	NULL
and	NULL
D.	NULL
Hayward	NULL
.	NULL

1990	NULL
.	NULL

The	NULL
Epstein-Barr	NULL
virus	NULL
Zta	NULL
transactivator	NULL
:	NULL
a	NULL
member	NULL
of	NULL
the	NULL
bZIP	NULL
family	NULL
with	NULL
unique	NULL
DNA-binding	NULL
specificity	NULL
and	NULL
a	NULL
dimerization	NULL
domain	NULL
that	NULL
lacks	NULL
the	NULL
characteristic	NULL
heptad	NULL
leucine	NULL
zipper	NULL
motif	NULL
.	NULL

J.	NULL
Virol	NULL
.	NULL

64:3358-3369.	NULL
.	NULL

Chasman	NULL
,	NULL
D.	NULL
L.	NULL
,	NULL
J.	NULL
Leatherwood	NULL
,	NULL
M.	NULL
Carey	NULL
,	NULL
M.	NULL
Ptashne	NULL
,	NULL
and	NULL
R.	NULL
D.	NULL
Kornberg	NULL
.	NULL

1989	NULL
.	NULL

Activation	NULL
of	NULL
yeast	NULL
polymerase	NULL
II	NULL
transcription	NULL
by	NULL
herpesvirus	NULL
VP16	NULL
and	NULL
GAL4	NULL
derivatives	NULL
in	NULL
vitro	NULL
.	NULL

Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

9:4746-4749	NULL
.	NULL

Countryman	NULL
,	NULL
J.	NULL
,	NULL
et	NULL
al	NULL
.	NULL

Unpublished	NULL
data	NULL
.	NULL

.	NULL

Countryman	NULL
,	NULL
J.	NULL
,	NULL
H.	NULL
Jenson	NULL
,	NULL
R.	NULL
Seibl	NULL
,	NULL
H.	NULL
Wolf	NULL
,	NULL
and	NULL
G.	NULL
Miller	NULL
.	NULL

1987	NULL
.	NULL

Polymorphic	NULL
proteins	NULL
encoded	NULL
within	NULL
BZFL	NULL
!	NULL

of	NULL
defective	NULL
and	NULL
standard	NULL
Epstein-Barr	NULL
viruses	NULL
disrupt	NULL
latency	NULL
.	NULL

J.	NULL
Virol	NULL
.	NULL

61:3672-3679.	NULL
.	NULL

Davis	NULL
,	NULL
M.	NULL
G.	NULL
,	NULL
and	NULL
E.	NULL
Huang	NULL
.	NULL

1988	NULL
.	NULL

Transfer	NULL
and	NULL
expression	NULL
of	NULL
plasmids	NULL
containing	NULL
cytomegalovirus	NULL
immediate	NULL
early	NULL
gene	NULL
1	NULL
promoter	NULL
enhancer	NULL
sequences	NULL
in	NULL
eukaryotic	NULL
and	NULL
prokaryotic	NULL
cells	NULL
.	NULL

Biotechnol	NULL
.	NULL

Appl	NULL
.	NULL

Biochem	NULL
.	NULL

10:6-12	NULL
.	NULL

Farrell	NULL
,	NULL
P.	NULL
J.	NULL
,	NULL
D.	NULL
T.	NULL
Rowe	NULL
,	NULL
C.	NULL
M.	NULL
Rooney	NULL
,	NULL
and	NULL
T.	NULL
Kouzarides	NULL
.	NULL

1989	NULL
.	NULL

Epstein-Barr	NULL
virus	NULL
BZLFI	NULL
trans-activator	NULL
specifically	NULL
binds	NULL
to	NULL
a	NULL
consensus	NULL
AP-1	NULL
site	NULL
and	NULL
is	NULL
related	NULL
to	NULL
c-fos	NULL
.	NULL

EMBO	NULL
J	NULL
.	NULL

8:127-132	NULL
.	NULL

Fields	NULL
,	NULL
S.	NULL
,	NULL
and	NULL
S.	NULL
K.	NULL
Jang	NULL
.	NULL

1990	NULL
.	NULL

Presence	NULL
of	NULL
a	NULL
potent	NULL
transcriptional	NULL
activating	NULL
sequence	NULL
in	NULL
the	NULL
p53	NULL
protein	NULL
.	NULL

Science	NULL
249:1046-1049.	NULL
.	NULL

Flemington	NULL
,	NULL
E.	NULL
K.	NULL
,	NULL
A.	NULL
M.	NULL
Borass	NULL
,	NULL
J.	NULL
P.	NULL
Lytle	NULL
,	NULL
and	NULL
S.	NULL
H.	NULL
Speck	NULL
.	NULL

1992	NULL
.	NULL

Characterization	NULL
of	NULL
the	NULL
Epstein-Barr	NULL
virus	NULL
BZLF1	NULL
protein	NULL
trans-activation	NULL
domain	NULL
.	NULL

J.	NULL
Virol	NULL
.	NULL

66:922-929.	NULL
.	NULL

Gill	NULL
,	NULL
G.	NULL
,	NULL
I.	NULL
Sadowski	NULL
,	NULL
and	NULL
M.	NULL
Ptashne	NULL
.	NULL

1990	NULL
.	NULL

Mutations	NULL
that	NULL
increase	NULL
the	NULL
activity	NULL
of	NULL
a	NULL
transcriptional	NULL
activator	NULL
in	NULL
yeast	NULL
and	NULL
mammalian	NULL
cells	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
§7:2127-2131.	NULL
.	NULL

Gill	NULL
,	NULL
G.	NULL
,	NULL
and	NULL
R.	NULL
Tjian	NULL
.	NULL

1991	NULL
.	NULL

A	NULL
highly	NULL
conserved	NULL
domain	NULL
of	NULL
TFIID	NULL
displays	NULL
species	NULL
specificity	NULL
in	NULL
vivo	NULL
.	NULL

Cell	NULL
65:333-340.	NULL
.	NULL

Giniger	NULL
,	NULL
E.	NULL
,	NULL
and	NULL
M.	NULL
Ptashne	NULL
.	NULL

1987	NULL
.	NULL

Transcription	NULL
in	NULL
yeast	NULL
activated	NULL
by	NULL
a	NULL
putative	NULL
amphipathic	NULL
«	NULL
helix	NULL
linked	NULL
to	NULL
a	NULL
DNA	NULL
binding	NULL
unit	NULL
.	NULL

Nature	NULL
(	NULL
London	NULL
)	NULL
330:670-672.	NULL
.	NULL

Giot	NULL
,	NULL
J.	NULL
,	NULL
I.	NULL
Mikaelian	NULL
,	NULL
M.	NULL
Buisson	NULL
,	NULL
E.	NULL
Manet	NULL
,	NULL
I.	NULL
Joab	NULL
,	NULL
J.	NULL
Nicolas	NULL
,	NULL
and	NULL
A	NULL
.	NULL

Sergeant	NULL
.	NULL

1991	NULL
.	NULL

Transcriptional	NULL
interference	NULL
between	NULL
the	NULL
EBV	NULL
transcription	NULL
factors	NULL
EB1	NULL
and	NULL
R	NULL
:	NULL
;	NULL
both	NULL
DNA-binding	NULL
and	NULL
activation	NULL
domains	NULL
of	NULL
EBI	NULL
are	NULL
required	NULL
.	NULL

Nucleic	NULL
Acids	NULL
Res	NULL
.	NULL

19:1251-1258	NULL
.	NULL

Gorman	NULL
,	NULL
C.	NULL
M.	NULL
,	NULL
L.	NULL
F.	NULL
Moffat	NULL
,	NULL
and	NULL
B.	NULL
H.	NULL
Howard	NULL
.	NULL

1982	NULL
.	NULL

Recombi-nant	NULL
genomes	NULL
which	NULL
express	NULL
chloramphenicol	NULL
acetyltransferase	NULL
in	NULL
mammalian	NULL
cells	NULL
.	NULL

Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

2:1044-1051	NULL
.	NULL

1992	NULL
.	NULL

Riding	NULL
high	NULL
on	NULL
the	NULL
TATA	NULL
box	NULL
.	NULL

Nature	NULL
(	NULL
London	NULL
)	NULL
360	NULL
:	NULL
16-17.	NULL
.	NULL

Himmelfarb	NULL
,	NULL
H.	NULL
J.	NULL
,	NULL
J.	NULL
Pearlberg	NULL
,	NULL
D.	NULL
H.	NULL
Last	NULL
,	NULL
and	NULL
M.	NULL
Ptashne	NULL
.	NULL

1990	NULL
.	NULL

GALIIP	NULL
:	NULL
a	NULL
yeast	NULL
mutation	NULL
that	NULL
potentiates	NULL
the	NULL
effect	NULL
of	NULL
weak	NULL
GAL4-derived	NULL
activators	NULL
.	NULL

Cell	NULL
63:1299-1309	NULL
,	NULL
Horikoshi	NULL
,	NULL
M.	NULL
,	NULL
T.	NULL
Yamamoto	NULL
,	NULL
Y.	NULL
Ohkuma	NULL
,	NULL
P.	NULL
A.	NULL
Weil	NULL
,	NULL
and	NULL
R.	NULL
G.	NULL
Roeder	NULL
.	NULL

1990	NULL
.	NULL

Analysis	NULL
of	NULL
structure-function	NULL
relationships	NULL
of	NULL
yeast	NULL
TATA	NULL
box	NULL
binding	NULL
factor	NULL
TFIID	NULL
.	NULL

Cell	NULL
16:1171-1178	NULL
.	NULL

Ingles	NULL
,	NULL
C.	NULL
J.	NULL
,	NULL
M.	NULL
Shales	NULL
,	NULL
W.	NULL
D.	NULL
Cress	NULL
,	NULL
S.	NULL
J.	NULL
Triezenberg	NULL
,	NULL
and	NULL
J.	NULL
Greenblatt	NULL
.	NULL

1991	NULL
.	NULL

Reduced	NULL
binding	NULL
of	NULL
TFIHD	NULL
to	NULL
transcription-ally	NULL
compromised	NULL
mutants	NULL
of	NULL
VP16	NULL
.	NULL

Nature	NULL
(	NULL
London	NULL
)	NULL
351:588-590.	NULL
.	NULL

Ito	NULL
,	NULL
H.	NULL
,	NULL
Y.	NULL
Fukuda	NULL
,	NULL
K.	NULL
Murata	NULL
,	NULL
and	NULL
A.	NULL
Kimura	NULL
.	NULL

1983	NULL
.	NULL

Transforma-	NULL
tion	NULL
of	NULL
intact	NULL
yeast	NULL
cells	NULL
treated	NULL
with	NULL
alkali	NULL
cations	NULL
.	NULL

J.	NULL
Bacteriol	NULL
.	NULL

153:163-168.	NULL
.	NULL

Johnston	NULL
,	NULL
M.	NULL
,	NULL
and	NULL
R.	NULL
W.	NULL
Davis	NULL
.	NULL

1984	NULL
.	NULL

Sequences	NULL
that	NULL
regulate	NULL
the	NULL
divergent	NULL
GALI-GALIO	NULL
promoter	NULL
in	NULL
Saccharomyces	NULL
cerevisiae	NULL
.	NULL

Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

4:1440-1448.	NULL
.	NULL

Kakidani	NULL
,	NULL
H.	NULL
,	NULL
and	NULL
M.	NULL
Ptashne	NULL
.	NULL

1988	NULL
.	NULL

GAL4	NULL
activates	NULL
gene	NULL
expres-	NULL
sion	NULL
in	NULL
mammalian	NULL
cells	NULL
.	NULL

Cell	NULL
52:161-167.	NULL
.	NULL

Lambert	NULL
,	NULL
P.	NULL
F.	NULL
,	NULL
N.	NULL
Dostatni	NULL
,	NULL
A	NULL
.	NULL

A.	NULL
McBride	NULL
,	NULL
M.	NULL
Yaniv	NULL
,	NULL
P.	NULL
M.	NULL
26	NULL
.	NULL

27	NULL
.	NULL

J.	NULL
Viror	NULL
.	NULL

Howley	NULL
,	NULL
and	NULL
B.	NULL
Arcangioli	NULL
.	NULL

1989	NULL
.	NULL

Functional	NULL
analysis	NULL
of	NULL
the	NULL
papilloma	NULL
virus	NULL
E2	NULL
frans-activator	NULL
in	NULL
Saccharomyces	NULL
cerevisiae	NULL
.	NULL

Genes	NULL
Dev	NULL
.	NULL

3:38-48.	NULL
.	NULL

Lech	NULL
,	NULL
K.	NULL
,	NULL
K.	NULL
Anderson	NULL
,	NULL
and	NULL
R.	NULL
Brent	NULL
.	NULL

1988	NULL
.	NULL

DNA-bound	NULL
fos	NULL
proteins	NULL
activate	NULL
transcription	NULL
in	NULL
yeast	NULL
.	NULL

Cell	NULL
52	NULL
;	NULL
179-184	NULL
.	NULL

Lieberman	NULL
,	NULL
P.	NULL
M.	NULL
,	NULL
and	NULL
A.	NULL
J.	NULL
Berk	NULL
.	NULL

1990	NULL
.	NULL

In	NULL
vitro	NULL
transcriptional	NULL
activation	NULL
,	NULL
dimerization	NULL
,	NULL
and	NULL
DNA-binding	NULL
specificity	NULL
of	NULL
the	NULL
Epstein-Barr	NULL
virus	NULL
Zta	NULL
protein	NULL
.	NULL

J.	NULL
Virol	NULL
.	NULL

64:2560-2568	NULL
.	NULL

Lieberman	NULL
,	NULL
P.	NULL
M.	NULL
,	NULL
and	NULL
A.	NULL
J.	NULL
Berk	NULL
.	NULL

1991	NULL
.	NULL

The	NULL
Zta	NULL
trans-activator	NULL
protein	NULL
stabilizes	NULL
TFIID	NULL
association	NULL
with	NULL
promoter	NULL
DNA	NULL
by	NULL
direct	NULL
protein-protein	NULL
interaction	NULL
.	NULL

Genes	NULL
Dev	NULL
.	NULL

5:2441-2454.	NULL
.	NULL

Lieberman	NULL
,	NULL
P.	NULL
M.	NULL
,	NULL
J.	NULL
M.	NULL
Hardwick	NULL
,	NULL
J	NULL
.	NULL

Sample	NULL
,	NULL
G.	NULL
S.	NULL
Hayward	NULL
,	NULL
and	NULL
S.	NULL
D.	NULL
Hayward	NULL
.	NULL

1990	NULL
.	NULL

The	NULL
Zta	NULL
transactivator	NULL
involved	NULL
in	NULL
induction	NULL
of	NULL
lytic	NULL
cycle	NULL
gene	NULL
expression	NULL
in	NULL
Epstein-Barr	NULL
virus	NULL
infected	NULL
lymphocytes	NULL
binds	NULL
to	NULL
both	NULL
AP-1	NULL
and	NULL
ZRE	NULL
sites	NULL
in	NULL
target	NULL
promoter	NULL
and	NULL
enhancer	NULL
regions	NULL
.	NULL

J.	NULL
Virol	NULL
.	NULL

64:1	NULL
143-1155	NULL
.	NULL

29	NULL
.	NULL

Lue	NULL
,	NULL
N.	NULL
F.	NULL
,	NULL
A.	NULL
R.	NULL
Buchman	NULL
,	NULL
and	NULL
R.	NULL
D.	NULL
Kornberg	NULL
.	NULL

1989	NULL
.	NULL

Activation	NULL
of	NULL
yeast	NULL
RNA	NULL
polymerase	NULL
II	NULL
transcription	NULL
by	NULL
a	NULL
thymidine-rich	NULL
upstream	NULL
element	NULL
in	NULL
vitro	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
86:486-490.	NULL
.	NULL

Ma	NULL
,	NULL
J.	NULL
,	NULL
and	NULL
M.	NULL
Ptashne	NULL
.	NULL

1987	NULL
.	NULL

Deletion	NULL
analysis	NULL
of	NULL
GAL4	NULL
defines	NULL
two	NULL
transcriptional	NULL
activating	NULL
segments	NULL
.	NULL

Cell	NULL
48:847-853.	NULL
.	NULL

Metzger	NULL
,	NULL
D.	NULL
,	NULL
J.	NULL
H.	NULL
White	NULL
,	NULL
and	NULL
P.	NULL
Chambon	NULL
.	NULL

1988	NULL
.	NULL

The	NULL
human	NULL
oestrogen	NULL
receptor	NULL
functions	NULL
in	NULL
yeast	NULL
.	NULL

Nature	NULL
(	NULL
London	NULL
)	NULL
334:31-36.	NULL
.	NULL

Miller	NULL
,	NULL
G.	NULL
1990	NULL
.	NULL

The	NULL
switch	NULL
between	NULL
latency	NULL
and	NULL
replication	NULL
of	NULL
Epstein-Barr	NULL
virus	NULL
.	NULL

J.	NULL
Infect	NULL
.	NULL

Dis	NULL
.	NULL

161:833-844.	NULL
.	NULL

Moore	NULL
,	NULL
P.	NULL
A.	NULL
,	NULL
S.	NULL
M.	NULL
Ruben	NULL
,	NULL
and	NULL
C.	NULL
A.	NULL
Rosen	NULL
.	NULL

1993	NULL
.	NULL

Conservation	NULL
of	NULL
transcriptional	NULL
activation	NULL
functions	NULL
of	NULL
the	NULL
NF-	NULL
«	NULL
B	NULL
p50	NULL
and	NULL
p65	NULL
subunits	NULL
in	NULL
mammalian	NULL
cells	NULL
and	NULL
Saccharomyces	NULL
cerevisiae	NULL
.	NULL

Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

13	NULL
;	NULL
1666-1674.	NULL
.	NULL

Morrissey	NULL
,	NULL
L.	NULL
C.	NULL
,	NULL
J.	NULL
Barsoum	NULL
,	NULL
and	NULL
E.	NULL
J.	NULL
Androphy	NULL
.	NULL

1989.	NULL
trans	NULL
activation	NULL
by	NULL
the	NULL
bovine	NULL
papillomavirus	NULL
E2	NULL
protein	NULL
in	NULL
Saccharomyces	NULL
cerevisiae	NULL
.	NULL

J.	NULL
Virol	NULL
.	NULL

63:4422-4425.	NULL
.	NULL

Nikotov	NULL
,	NULL
D.	NULL
B.	NULL
,	NULL
S.-H.	NULL
Hu	NULL
,	NULL
J.	NULL
Lin	NULL
,	NULL
A.	NULL
Gasch	NULL
,	NULL
A.	NULL
Hoffman	NULL
,	NULL
M.	NULL
Horikoshi	NULL
,	NULL
N.-H.	NULL
Chua	NULL
,	NULL
R.	NULL
G.	NULL
Roeder	NULL
,	NULL
and	NULL
S.	NULL
K.	NULL
Burley	NULL
.	NULL

1992	NULL
.	NULL

Crystal	NULL
structure	NULL
of	NULL
TFIID	NULL
TATA-box	NULL
binding	NULL
protein	NULL
.	NULL

Nature	NULL
(	NULL
London	NULL
)	NULL
360:40-46	NULL
.	NULL

36	NULL
.	NULL

Packham	NULL
,	NULL
G.	NULL
,	NULL
A.	NULL
Economu	NULL
,	NULL
C.	NULL
M.	NULL
Rooney	NULL
,	NULL
D.	NULL
T.	NULL
Rowe	NULL
,	NULL
and	NULL
P.	NULL
J	NULL
.	NULL

40	NULL
.	NULL

41	NULL
.	NULL

46	NULL
.	NULL

47	NULL
.	NULL

48	NULL
.	NULL

Farrell	NULL
.	NULL

1990	NULL
.	NULL

Structure	NULL
and	NULL
function	NULL
of	NULL
the	NULL
Epstein-Barr	NULL
virus	NULL
BZLFI	NULL
protein	NULL
.	NULL

J.	NULL
Virol	NULL
.	NULL

64:2110-2116.	NULL
.	NULL

Ptashne	NULL
,	NULL
M.	NULL
1988	NULL
.	NULL

How	NULL
cukaryotic	NULL
transcriptional	NULL
activators	NULL
work	NULL
.	NULL

Nature	NULL
(	NULL
London	NULL
)	NULL
335:683-689.	NULL
.	NULL

Ptashne	NULL
,	NULL
M.	NULL
,	NULL
and	NULL
A	NULL
.	NULL

A.	NULL
F.	NULL
Gann	NULL
.	NULL

1990	NULL
.	NULL

Activators	NULL
and	NULL
targets	NULL
.	NULL

Nature	NULL
(	NULL
London	NULL
)	NULL
346:329-331.	NULL
.	NULL

Pugh	NULL
,	NULL
B.	NULL
F.	NULL
,	NULL
and	NULL
R.	NULL
Tjian	NULL
.	NULL

1992	NULL
.	NULL

Diverse	NULL
transcriptional	NULL
functions	NULL
of	NULL
the	NULL
multisubunit	NULL
eukaryotic	NULL
TFIID	NULL
complex	NULL
.	NULL

J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

267:679-682	NULL
.	NULL

Sadowski	NULL
,	NULL
L.	NULL
,	NULL
J.	NULL
Ma	NULL
,	NULL
S.	NULL
Triezenberg	NULL
,	NULL
and	NULL
M.	NULL
Ptashne	NULL
.	NULL

1988	NULL
.	NULL

GALA4-VP16	NULL
is	NULL
an	NULL
unusually	NULL
potent	NULL
transcriptional	NULL
activator	NULL
.	NULL

Nature	NULL
(	NULL
London	NULL
)	NULL
335:536-569	NULL
.	NULL

Sadowski	NULL
,	NULL
I.	NULL
,	NULL
and	NULL
M.	NULL
Ptashne	NULL
.	NULL

1989	NULL
.	NULL

A	NULL
vector	NULL
for	NULL
expressing	NULL
GALA	NULL
(	NULL
1-147	NULL
)	NULL
fusions	NULL
in	NULL
mammalian	NULL
cells	NULL
.	NULL

Nucleic	NULL
Acids	NULL
Res	NULL
.	NULL

17:7539	NULL
.	NULL

2	NULL
.	NULL

Schena	NULL
,	NULL
M.	NULL
,	NULL
and	NULL
K.	NULL
Yamamoto	NULL
.	NULL

1988	NULL
.	NULL

Mammalian	NULL
glucocorticoid	NULL
receptor	NULL
derivatives	NULL
enhance	NULL
transcription	NULL
in	NULL
yeast	NULL
.	NULL

Science	NULL
241	NULL
:	NULL
965-967.	NULL
.	NULL

Sherman	NULL
,	NULL
F.	NULL
,	NULL
G.	NULL
Fink	NULL
,	NULL
and	NULL
C.	NULL
Lawrence	NULL
.	NULL

1983	NULL
.	NULL

Mcthods	NULL
in	NULL
yeast	NULL
genetics	NULL
.	NULL

Cold	NULL
Spring	NULL
Harbor	NULL
Laboratory	NULL
,	NULL
Cold	NULL
Spring	NULL
Harbor	NULL
,	NULL
N.Y.	NULL
.	NULL

Stone	NULL
,	NULL
G.	NULL
,	NULL
and	NULL
I.	NULL
Sadowski	NULL
.	NULL

GAL4	NULL
is	NULL
regulated	NULL
by	NULL
a	NULL
glucose	NULL
responsive	NULL
functional	NULL
domain	NULL
.	NULL

EMBO	NULL
J.	NULL
,	NULL
in	NULL
press	NULL
.	NULL

.	NULL

Struhl	NULL
,	NULL
K.	NULL
1988	NULL
.	NULL

The	NULL
Jun	NULL
oncoprotein	NULL
,	NULL
a	NULL
vertebrate	NULL
transcription	NULL
factor	NULL
,	NULL
activates	NULL
transcription	NULL
in	NULL
yeast	NULL
.	NULL

Nature	NULL
(	NULL
London	NULL
)	NULL
332:649-650	NULL
.	NULL

Swaffield	NULL
,	NULL
J.	NULL
C.	NULL
,	NULL
J.	NULL
F.	NULL
Bromfield	NULL
,	NULL
and	NULL
S.	NULL
A.	NULL
Johnston	NULL
.	NULL

1992	NULL
.	NULL

Alterations	NULL
in	NULL
a	NULL
yeast	NULL
protein	NULL
resembling	NULL
HIV	NULL
Tat-binding	NULL
protein	NULL
relieve	NULL
requirement	NULL
for	NULL
an	NULL
acidic	NULL
activation	NULL
domain	NULL
in	NULL
GALA	NULL
.	NULL

Nature	NULL
(	NULL
London	NULL
)	NULL
357:698-700	NULL
.	NULL

Taylor	NULL
,	NULL
N.	NULL
,	NULL
E.	NULL
K.	NULL
Flemington	NULL
,	NULL
J.	NULL
L.	NULL
Kolman	NULL
,	NULL
R.	NULL
P.	NULL
Baumann	NULL
,	NULL
S.	NULL
H.	NULL
Speck	NULL
,	NULL
and	NULL
G.	NULL
Miller	NULL
.	NULL

1991	NULL
.	NULL

ZEBRA	NULL
and	NULL
a	NULL
Fos-GCN4	NULL
chimeric	NULL
protein	NULL
differ	NULL
in	NULL
their	NULL
DNA-binding	NULL
specificities	NULL
for	NULL
sites	NULL
in	NULL
the	NULL
Epstein-Barr	NULL
virus	NULL
BZLFI1	NULL
promoter	NULL
.	NULL

J.	NULL
Virol	NULL
.	NULL

65:4033-4041	NULL
.	NULL

Triezenberg	NULL
,	NULL
S.	NULL
,	NULL
R.	NULL
Kingsbury	NULL
,	NULL
and	NULL
S.	NULL
McKnight	NULL
.	NULL

1989	NULL
.	NULL

Functional	NULL
dissection	NULL
of	NULL
VP16	NULL
,	NULL
the	NULL
trans-activator	NULL
of	NULL
herpes	NULL
simplex	NULL
virus	NULL
immediate	NULL
early	NULL
gene	NULL
expression	NULL
.	NULL

Genes	NULL
Dev	NULL
.	NULL

2:718-729	NULL
.	NULL

Vor	NULL
.	NULL

67	NULL
,	NULL
1993	NULL
FUNCTIONS	NULL
OF	NULL
ZEBRA	NULL
REGIONS	NULL
IN	NULL
YEAST	NULL
AND	NULL
B	NULL
CELLS	NULL
7481	NULL
49	NULL
.	NULL

Urier	NULL
,	NULL
B.	NULL
,	NULL
M.	NULL
Buisson	NULL
,	NULL
P.	NULL
Chambard	NULL
,	NULL
and	NULL
A	NULL
.	NULL

Sergeant	NULL
.	NULL

1989	NULL
.	NULL

The	NULL
T-cell	NULL
leukemia	NULL
virus	NULL
type	NULL
I	NULL
in	NULL
Saccharomyces	NULL
cerevisiae	NULL
.	NULL

J.	NULL
Virol	NULL
.	NULL

Epstein-Barr	NULL
virus	NULL
early	NULL
protein	NULL
EB1	NULL
activates	NULL
transcription	NULL
from	NULL
66:7253-7261.	NULL
different	NULL
responsive	NULL
elements	NULL
including	NULL
AP-1	NULL
binding	NULL
sites	NULL
.	NULL

EMBO	NULL
51	NULL
.	NULL

Yocum	NULL
,	NULL
R.	NULL
R.	NULL
,	NULL
S.	NULL
Hanley	NULL
,	NULL
R.	NULL
West	NULL
,	NULL
Jr.	NULL
,	NULL
and	NULL
M.	NULL
Ptashne	NULL
.	NULL

1984	NULL
.	NULL

Use	NULL
J	NULL
.	NULL

8:1447-1453.	NULL
of	NULL
LacZ	NULL
fusions	NULL
to	NULL
delimit	NULL
regulatory	NULL
elements	NULL
of	NULL
the	NULL
inducible	NULL
50	NULL
.	NULL

Wu	NULL
,	NULL
L.-C.	NULL
,	NULL
T.-H.	NULL
Tan	NULL
,	NULL
and	NULL
S.	NULL
I.	NULL
Shahied	NULL
.	NULL

1992	NULL
.	NULL

Expression	NULL
and	NULL
divergent	NULL
GALI-GAL1O	NULL
promoter	NULL
in	NULL
Saccharomyces	NULL
cerevisiae	NULL
.	NULL

characterization	NULL
of	NULL
the	NULL
franms-activating	NULL
protein	NULL
Tax	NULL
of	NULL
human	NULL
Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

41985-1998	NULL
.	NULL

